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Technical specifications for a European baseline survey 
of norovirus in oysters 
European Food Safety Authority (EFSA) 
Abstract 
The European Commission requested scientific technical assistance in the preparation of a survey 
protocol for a European Union (EU) coordinated monitoring programme on the prevalence of 
norovirus (NoV) in raw oysters. The objective of the survey is to estimate the European prevalence of 
norovirus-contaminated oysters at production areas and batches of oysters at dispatch centres, with a 
95% level of confidence and a level of precision of 5% considering an expected prevalence of 50%. 
The survey protocol defines the target population, the sample size for the survey, sample collection 
requirements, the analytical method for the quantification of NoV copy number (genotype I and 
genotype II), the data reporting requirements and the plan of analysis. The sample unit in production 
areas is a classified production area actively growing commercial oysters (whether harvesting or not is 
occurring) and for dispatch centres is a quantity of live oysters which are being packed and labelled 
with an Identification Mark. Based on a multistage sampling scheme, 1,026 samples from 171 
production areas and 1,182 samples from 197 dispatch centres should be taken annually in Europe. 
To reduce the probability of surveying an atypical year, the survey is to be repeated for a second year. 
The samples are to be analysed according to the method specification developed by the European 
Union Reference Laboratory (EURL) expert working group, which is compliant with ISO/DIS 15216-1. 
Generalised linear models will be used to estimate proportion (with 95% confidence intervals) of 
sample units with NoV contamination for the following thresholds: < limit of quantification (LOQ), 100, 
200, 500, 1,000, 5,000, 10,000 and > 10,000 copies/g. The necessary data to be reported by the 
sampler and the laboratory to support this analysis is presented in two data models. The results of the 
survey should be reported using the EFSA data collection framework. 
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1. Introduction  
1.1. Background and Terms of Reference as provided by the requestor 
Noroviruses (NoV) are known to cause ‘winter-vomiting disease’ or ‘stomach-flu’ referring to their 
rapid spread in human populations especially during winter months. They are transmitted primarily 
through the faecal-oral route, either by consumption of contaminated food or water, or by spreading 
directly from person to person. Many different food items have been associated with NoV outbreaks. 
Raspberries and oysters have caused several national and international outbreaks. 
Bivalve molluscs are a well-documented source of noroviral infection since they have the ability to 
accumulate and concentrate NoV particles by filtration of water contaminated with faeces. NoV 
associated with point source human faecal pollution (e.g. discharges from sewage treatment works) 
is a persistent problem in coastal waters during the winter months leading to the contamination of 
bivalve mollusc production areas. Oysters contaminated with NoV pose a particular risk to human 
health since they are routinely consumed raw. 
There is currently no threshold infectivity limit established for NoV as detected by polymerase chain 
reaction (PCR). The probability of becoming infected increases with the dose but depends also on the 
characteristics of the organism, the food matrix and the host factors. 
Furthermore, the relationship between the number of infectious virus particles and the number of 
virus genome copies detected by quantitative PCR is not a constant, and it is important to realise that 
the infectious risk associated with low level positive oysters, as determined by real-time PCR, may be 
overestimated. 
In accordance with Article 31 of Regulation (EC) No 178/2002, EFSA is requested to provide scientific 
and technical assistance on design related to an EU coordinated monitoring programme on the 
prevalence of NoV in raw oysters, and in particular to: 
Prepare a survey protocol for the baseline survey of NoV contamination in oysters in the EU with the 
objective to: 
a) Assess the proportion of EU classified production areas with NoV contamination. The survey 
should detect at least 1% of representative monitoring points within harvesting areas with > 1,000 
total NoV PCR copies per gram with a level of confidence of 95%; 
b) Assess the proportion of batches of final product at approved EU dispatch centres with NoV 
contamination. The survey should be able to detect batches with > 1,000 total NoV PCR copies per 
gram with a level of confidence of 95% and a level of precision of 5% and an expected prevalence of 
50%. 
1.2. Interpretation of the Terms of Reference  
The working group agreed that the objective of the survey is to estimate the likelihood that a sample 
unit is contaminated with NoV. As a consequence, the working group proposed an interpretation of 
the survey objective for classified production areas as the estimation of prevalence of NoV in that 
population.  
The baseline survey should assess the proportion of European Union (EU) classified oyster production 
areas with NoV contamination. The survey should estimate the prevalence of norovirus (> 1,000 
total NoV PCR copies/g) in oysters collected from representative monitoring points within production 
areas with a level of confidence of 95% and a level of precision of 5% and considering an expected 
prevalence of 50%. 
The estimation of prevalence based on viral copy number (> 1,000 total NoV PCR copies/g) is 
primarily included in the survey objectives to indicate that the survey requires the quantification of 
viral RNA to be reported rather than just the detection of viral RNA.  The final data analysis will 
present the proportion of contaminated production areas/batches of final product for a 
range of NoV copy number thresholds (below limit of quantification (LOQ), 100, 200, 500, 
1,000, 5,000, 10,000 and greater than 10,000 copies/g) in order to refine the analysis 
presented in EFSA BIOHAZ Panel, 2012.  
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An expected prevalence of 50% is specified in the objective as this represents the maximum 
variability and therefore the largest sample size. For thresholds based on a lower copy number than 
1,000 where the expected prevalence could be greater than 50% this sample size is more than 
sufficient to achieve the required precision. In general, a higher level of precision is achieved if the 
prevalence at a specific copy number threshold is greater or lower than 50% (Bartlett et al 2001).  
2. Data and Methodologies  
2.1. Survey design 
2.1.1. Survey objectives 
Survey objectives can broadly be divided into two groups: estimation or inferential. Estimation 
objectives mainly involve production of quantitative and numerical descriptions (estimation) of 
relevant aspects of a target population, like the population mean or the population total, mean 
difference between two groups of the same population and proportion of the population with a trait 
of interest, etc. On the other hand, inferential objectives are about testing a particular hypothesis 
about the population of interest, examples include, testing that the population mean is greater (less) 
than a certain value, or that means of groups of the same population are not equal (Milanzi et al, 
2015). For the baseline survey, we are seeking to estimate the likelihood that a sample unit is 
contaminated with NoV. 
The first objective is to estimate the prevalence of norovirus-contaminated (> 1,000 total NoV PCR 
copies/gram) oyster production areas, at EU level, with a level of confidence of 95% and a level of 
precision of 5% and considering an expected prevalence of 50% 
The second objective is to estimate the prevalence of norovirus-contaminated (> 1,000 total NoV 
PCR copies/gram) batches at approved dispatch centres, at EU level, with a level of confidence of  
95% and a level of precision of 5% and considering an expected prevalence of 50%. 
A clear definition of targeted population is important to determine the extent to which results from 
the survey can be generalised (Milanzi et al, 2015).  
In Europe, oyster production is primarily comprised of two species: flat oysters (Ostrea edulis) and 
Pacific cupped oysters (Crassostrea gigas). 1 The production of Portuguese oysters (Crassostrea 
angulata) was reported in production areas in Spain and Portugal (information received from EU 
Member State (MS) Competent Authorities represented on Commission working group on live bivalve 
molluscs (LBM)). A study of artificial contamination of O. edulis and C. gigas with NoV at a range of 
concentrations concluded that there was no evidence that the performance of the detection method 
varied significantly between the two oyster species (CEFAS 2011). It is assumed that there will be no 
significant difference between the three species being produced in Europe. Therefore, the oyster 
species O. edulis, C. gigas and C. angulata are to be sampled in the survey. Only live oysters are to 
be sampled for the survey. 
The terms of reference request both ‘representative monitoring points within harvesting areas’ and 
‘batches of final product from approved EU dispatch centres’ to be included in the survey. Therefore, 
survey requires samples to be taken at two points in the food chain. Sampling in production areas is 
closer to the source of contamination whereas sampling oysters as they leave the dispatch centre is 
closer to the consumer exposure. The inclusion of both locations will ensure that suitable data is 
available to support a decision with regard to setting a microbiological criterion for NoV. 
  
                                                          
1 http://ec.europa.eu/fisheries/cfp/aquaculture/aquaculture_methods/index_en.htm  
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Production areas 
Harvesting areas include both production areas and relaying areas (EC, 2012). ‘Production area’ 
means any sea, estuarine or lagoon area, containing either natural beds of bivalve molluscs or sites 
used for the cultivation of bivalve molluscs, and from which live bivalve molluscs are taken. ‘Relaying 
area’ means any sea, estuarine or lagoon area with boundaries clearly marked and indicated by 
buoys, posts or any other fixed means, and used exclusively for the natural purification of live bivalve 
molluscs.2 
The production areas from which harvesting of bivalve molluscs is authorised are divided into three 
classes based on monitoring results for the bacterial indicator organism Escherichia coli: 
Class A areas: Areas from which molluscs may be collected for direct human consumption (less than 
or equal to 230 E. coli/100 g of flesh and intravalvular liquid in 80% of samples. The remaining 20% 
must not exceed 700 E. coli/100 g flesh and intravalvular liquid).3 
Class B areas: Areas from which molluscs may be collected but may only be placed on the market for 
human consumption after treatment in a purification centre, after relaying or after an approved heat 
treatment (less than or equal to 4,600 E. coli/100 g of flesh and intravalvular liquid (in 90% of 
samples and no sample more than 46,000 E. coli/100 g of flesh and intravalvular liquid)). 4 
Class C areas: Areas from which molluscs may be collected but may only be placed on the market 
after relaying over a long period (as a general rule, at least 2 months) whether or not combined with 
purification or after an approved heat treatment (less than or equal to 46,000 E. coli/100 g flesh and 
intravalvular liquid).4 
The classification status of a production area can vary with time and is dependent on the E. coli 
monitoring results. Full classification is based on results from an extensive number of sampling 
occasions to ensure that potential seasonal and annual variability has been fully covered. Seasonal 
classification is given when there is a clear seasonal trend over a number of seasons and, 
consequently, different classification categories apply for different seasons (EC, 2012). Class A, B and 
C production areas are to be included in the survey. 
A representative sampling point is a specified geographical location from which samples are taken to 
represent either a single or several, wild bivalve mollusc beds or aquaculture sites. The 
representative sampling point should reflect the location at highest risk of faecal pollution within the 
classified area. For offshore areas (> 5 km from shore) not impacted by point discharges (according 
to the sanitary survey) random sampling points within the classified area may be used. 
In order to ensure that a suitable sample of live oysters for laboratory analysis can be obtained, the 
target population is defined as classified production areas actively growing commercial 
oysters (whether harvesting or not is occurring). Approved relaying areas are excluded 
for logistic reasons, since they are only used for natural purification for limited periods in the year. A 
commercial oyster is defined as an oyster that is of sufficient maturity to enter the production chain 
for consumption.  
Dispatch centres 
‘Dispatch centre’ means any onshore or offshore establishment for the reception, conditioning, 
washing, cleaning, grading, wrapping and packaging of LBM fit for human consumption2. Dispatch 
centres are approved by the Competent Authority (CA) and assigned a unique approval number 
(Appendix D). 
‘Batch’ means a group or set of identifiable products obtained from a given process under practically 
identical circumstances and produced in a given place within one defined production period5  
                                                          
2  Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific hygiene 
rules for food of animal origin 
3  Commission Regulation (EU) 2015/2285 amending Annex II to Regulation (EC) No 854/2004 of the European Parliament and 
of the Council laying down specific rules for the organisation of official controls on products of animal origin intended for 
human consumption as regards certain requirements for live bivalve molluscs, echinoderms, tunicates and marine 
gastropods and Annex I to Regulation (EC) No 2073/2005 on microbiological criteria for foodstuffs. 
4   Regulation (EC) No 854/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific rules for 
the organisation of official controls on products of animal origin intended for human consumption. 
5  Commission Regulation (EC) No 2073/2005 of 15 November 2005 on microbiological criteria for foodstuffs  
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For the purposes of the survey, a batch of final product means a quantity of live oysters, which 
are being packed and labelled with an Identification Mark. This quantity of oysters should 
have a single unique batch identifier in the dispatch centre internal traceability system. 
In line with permitted activities under EU legislation, the following batches can be included for 
sampling: 
 batches containing oysters from one or multiple production areas; 
 batches containing oysters from European or third country production areas; 
 batches containing class A, B or C oysters following, if necessary, purification, conditioning or 
relaying; 
 batches containing oysters from existing batches, which are being reassembled into smaller 
or larger packages for individual customers. 
Figure 1 is a generalised schematic illustrating relationship between production areas and dispatch 
centres, and the processes that can be applied to molluscs prior to placing on the market for 
consumption. Three processes can be applied to molluscs prior to consumption depending on the 
classification of the production area from which they were harvested.  
Conditioning is the storage of LBM coming from class A production areas, purification centres or 
dispatch centres in tanks or any other installation containing clean seawater, or in natural sites, to 
remove sand, mud or slime, to preserve or to improve organoleptic qualities and to ensure that they 
are in a good state of vitality before wrapping or packaging. Conditioning is not performed in all 
dispatch centres.  
Relaying is the transfer of LBM to sea, lagoon or estuarine areas for the time necessary to reduce 
contamination to make them fit for human consumption. This does not include the specific operation 
of transferring bivalve molluscs to areas more suitable for further growth or fattening. 
Purification treatment is performed in tanks fed by clean seawater in which LBM are placed for the 
time necessary to reduce contamination to make them fit for human consumption 
In some cases, the production chain can be more complex and there may be regional variations 
depending on local conditions and production practices. 
 
 
Figure 1: Schematic of the production chain for bivalve molluscs 
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2.1.2. Sampling frame 
Representative sampling points within production areas  
Regulation (EC) No 854/2004 specifies that the CA must fix the location and the boundaries of 
production areas for bivalve molluscs. In some cases, there may be more than one representative 
sampling point within a classified production area. For the baseline survey, a single representative 
sampling point within a production area should be selected for sampling the oysters. This should be 
the sampling point with highest levels of E. coli contamination based on the routine monitoring 
performed under Regulation (EC) No 854/2004 (see Section 2.2.1 for more details). 
Information on classified oyster production areas was requested from the MSs by the European 
Union Reference Laboratory (EURL) and a summary is presented in Table 1. In May 2015, there were 
422 classified production areas that had produced oysters in the last 12 months in 13 countries (12 
MS plus Norway). In order to refine the sampling plan at MS level, the number of representative 
sampling points per production area, information on the current status of production areas and the 
availability of commercial size oysters throughout the year should be obtained prior to starting the 
survey. Figure 2 shows the population hierarchy considered in the survey design for sampling from 
production areas. 
Batches of final product from approved EU dispatch centres 
Approved dispatch centres apply Identification Marks at the point of packing and wrapping prior 
sending the batches to their customers. Information on approved dispatch centres was requested 
from the MS by the EURL and a summary is presented in Table 1. In May 2015, there were 2,325 
approved dispatch centres that had packed oysters in the last 12 months in 13 countries (12 MS plus 
Norway). Prior to starting the survey, the operational status of approved dispatch centres within a 
MS should be confirmed. In addition, information on the batches produced monthly in the dispatch 
centres in 2014 should be obtained. If this information is not available, production volumes per 
dispatch centre in kilograms could be used as a proxy. This information would allow refinement of 
the sampling plan at MS level and adjustment of the timing of sampling around seasonal fluctuations 
in availability of oysters. Figure 3 shows the population hierarchy considered in the survey design for 
sampling of batches of final product from dispatch centres. 
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Table 1:  Number of classified oyster production areas and number of approved dispatch centres 
packaging oysters (Summary of information received from Competent Authorities 
represented on Commission working group on LBM, May 2015) 
 Production Areas Dispatch Centres  
 
Total 
(a) 
Active Not 
Active 
Don't 
Know 
Total Active Not 
Active 
Don't 
Know 
Croatia 6 5 1  9 9   
Denmark 6 6   5 5   
France 201 189 4 8(c) 2442 2015  427 
Germany 6 1  5 3 2 1  
Greece 3 3   3 3   
Iceland 1  1  0    
Ireland 66 56 10  12 12   
Italy 37 18 17 2 161 110 47 4 
Netherlands 11 11   34 33 1  
Norway 3 3   3 1 2  
Portugal 16 11  5 30 21 9  
Romania 1  1  0    
Spain 121 34(d) 263(d) 33(d) 70 70   
Sweden 10 6 4  5 3(b) 3(b)  
United 
Kingdom 
80 79 1  46 41 5  
Total  422    2,325   
LBM: live bivalve molluscs 
(a): Totals may vary depending on the number of species present in the production area 
(b): Combined data for C. gigas and O. edulis 
(c): Storage areas, in development, small production 
(d): Combined data for C. gigas, O. edulis and C. angulata 
 
 
Figure 2:  Schematic of the hierarchy within the population for production areas 
Every country producing oysters is selected, the countries are considered to be strata and a proportion of production areas are 
randomly selected within the country, in each production area a single representative sampling point (representing the highest 
level of E. coli contamination) is selected to obtain samples of oysters (yellow indicates inclusion in the survey) 
Target population: Representative sampling points within EU 
production areas 
Country 1 
Production  
area 1 
Sampling 
point 1 
Country 2 
Production 
 area 1 
Sampling 
point 1 
Sampling 
point 2 
Production  
area 2 
 Sampling  
point 1 
Country M 
Production 
 area 1 
Sampling  
point 1 
Sampling  
point 2 
Sampling  
point 3 
Sampling  
point 4 
Production  
area 2 
 Sampling  
point 1 
Production  
area 3 
Sampling 
 point 1 
Sampling  
point 2 
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Figure 3: Schematic of the hierarchy within the population for dispatch centres for a two monthly 
period 
Every country dispatching oysters is selected, the countries are considered to be strata and a proportion of dispatch centres 
are randomly selected within the country, each dispatch centre is considered to be a cluster and a batch of oysters within the 
dispatch centre is selected to obtain a sample of oysters within a two monthly period (yellow indicates inclusion in the survey) 
2.1.3. Sample size 
Simple random sample scheme 
Sample size calculation formulas presented in this section are based on estimation of the parameter 
of interest (in this case, the prevalence at EU level of NoV-contaminated oyster active production 
areas and of NoV-contaminated batches in dispatch centres). The rationale behind the calculation is 
to first fix the desired margin of error ( ), and as   is a function of sample size ( ), then by fixing all 
other parameters, the required sample size can be obtained (Equation 1).  
When estimation of the prevalence of NoV in the targeted population is of interest, it is important to 
achieve the highest precision practically possible. Sample size calculations, considering simple 
random sampling schemes (SRS), are used to obtain a desired level of precision. The sample size   
can be obtained as: 
  
     
  
  (1) 
 
where   is the margin of error, defined as the error which the risk manager is willing to accept in 
estimating the prevalence of NoV-contaminated production areas or batches and   is the normal 
quantile of   (type I error), the risk that the true margin of error exceeds the acceptable margin of 
error, (Bartlett, et.al, 2001).    represents the expected variability for SRS, which in this case could 
be estimated as     ̅  (   ̅), where   ̅ is the expected prevalence. 
For the purposes of the NoV baseline survey,   (type I error) is 0.05, the margin of error ( ) 
considered is 0.05 and        . 
Normality assumptions are made implying that sample sizes obtained are based on the consideration 
of an infinite population. This assumption can be relaxed when dealing with finite populations; the 
final sample size for a finite population can be adjusted using Equation 2: 
   
   
     
 (2) 
Target population: batches of final product from approved EU dispatch 
centres 
Country A 
Dispatch 
centre 1 
Batch 1 
Batch 2 
Batch NA1 
Dispatch 
centre 2 
Batch 1 
Batch 2 
Batch NA2 
Country B 
Dispatch 
centre 1 
Batch 1 
Batch 2 
Batch NB1 
Country M 
Dispatch 
centre 1 
Batch 1 
Dispatch 
centre 2 
Batch 1 
Batch 2 
Batch NM2 
Dispatch 
centre 3 
Batch 1 
Batch 2 
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For the purposes of the NoV baseline survey in both production areas and dispatch centres, the 
oyster producing countries are considered as strata. 
The target population is composed of   units (422 production areas and batches processed in 2,325 
dispatch centres during the year of survey) which are divided into    strata (Ireland, Greece, 
Denmark, Sweden, France, Spain, the United Kingdom, the Netherlands, Croatia, Germany, Portugal, 
Norway and Italy), each of size    (Table 1, presents the number of production areas and dispatch 
centres per country, that are used to construct the weights),         . Let ‘weights’    
  
 
 denote the population proportion of the strata. Simple random samples are drawn separately 
within each stratum. 
For the estimation of the population prevalence ̅, the stratified estimator is given as  
 ̅      ̅     ̅        ̅   ∑   
  
    ̅  , 
with  ̅  the stratum sample prevalence. The variance of this estimator, ignoring the finite population 
correction factor, is expressed as  
   ( ̅  )  ∑  
 
 
   
  
 
  
 ∑  
 
 
   
 ̅  (   ̅ )
  
  (3) 
 
Under proportional allocation (   
  
 
  ), similar procedure as the one used to obtain Equation (1) 
can be applied using Equation (3) resulting in the formula to calculate the sample size for stratified 
sampling schemes given below  
  
  
  
∑
  
 
  
  
 
 (4) 
 
Considering finite population correction, the equation to calculate    (Equation (2)) is used here with 
  replaced by Equation (4). 
A stratified sampling scheme uses both the proportions provided in Table 1 and previously reported 
prevalence (if available) to calculate the weights required for the sample size calculation. However, in 
order to ensure that the proposed sample size accounts for maximum variability, the value used for 
the expected prevalence for each of the countries is fixed at 0.5. 
Under these assumptions, the total sample size for the production areas and batches at dispatch 
centres in the EU considering the information available and Equation (4), which reduces to equation 
(1) for an infinite population is: 
  
      
     
                 
The number of batches of oysters produced in the EU is large and can be considered to be infinite 
(Appendix A), however, in May 2015, only 422 production areas were active within Europe. Therefore, 
production areas can be considered finite. Over a year, there will be changes to the oyster population 
with repopulation and depopulation occurring. Therefore, the number of production areas is 
multiplied by a factor for monthly variation (12), resulting in a finite population size of 5,064. The 
resulting sample size is: 
   
        
          
            
Using a simple random sampling scheme the total number of samples in the EU to be 
taken to achieve the precision specified above and adjusted for proportional allocation is 
358 for production areas and 385 batches from dispatch centres.  
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Multistage sample scheme 
Simple random sampling ignores some of the complexities inherent in natural systems. The survey 
design requires a balance between a spatially and temporally representative sampling scheme, the 
total volume of samples, which can be effectively collected, processed and analysed, and the overall 
cost of the survey. In the sampling schemes presented above, the sampling units are assumed to be 
independent, however, this is often not the case especially if multiple samples are taken from a 
cluster (e.g. production areas and dispatch centres). 
The Centre for Environment, Fisheries & Aquaculture Science (CEFAS) survey in 2009/2011 in the UK 
in oyster production areas indicated that both the prevalence and the level of NoV varied markedly 
between seasons (Figure 4). Strong winter seasonality was observed. Ninety per cent of the samples 
taken between October and March were positive compared with 62.4% of samples taken between 
April and September. Highest levels were detected between December and March (CEFAS, 2011). 
The EFSA BIOHAZ Panel (2012) also reported strong winter seasonality for NoV contamination in 
oysters when comparing surveillance data from Ireland, the UK and France. In order to account for 
temporal variation, multiple samples would need to be taken from the same production area and 
they may be correlated.  
Where sampling units are not independent, the sample size can be obtained by adjusting the 
variance with the design effect ([   (   )]). It is important to highlight that under a cluster 
sampling design, clusters in the population to be sampled are randomly selected and all elements 
within a cluster are included. This sampling scheme can be used when the cluster sizes are small. For 
large clusters, multistage sampling designs are proposed instead. Multistage sampling designs use 
design effects to ensure that the correlation between sampling units from the same clusters are 
accounted for when calculating sample size. For multistage designs, sample size can be obtained as: 
  [   (   )]  
    
  
 (5) 
 
where   reflects the correlation between units within same cluster and   reflects the number of 
elements within a cluster that will be sampled. The remainder of the parameters remain as defined in 
the simple random sample scheme (Equation (1)). 
In order to estimate potential correlation among samples from different months within a production 
area, data collected in the UK was used (CEFAS, 2011). The resulting model, accounting for 
seasonality, contains linear and quadratic time effect, as a fixed effect, and a production area as a 
specific random effect. The results obtained for the fitted model are presented in Figure 4. The 
variability associated with the random effect (1.54, C.I.: 0.91–1.71) estimated from the final model 
could be used to estimate the correlation (see p. 27 from EFSA, 2013a) among measurements taken 
within the production areas to calculate the sample size. The obtained correlation is 0.28 (C.I.: 0.18–
0.30), using Equation (5), the design effect, considering sampling bimonthly in each production area 
selected (   , would be 2.4 (C.I.: 1.9–2.5).  
Similarly, for dispatch centres the sampling unit is batches, these could be correlated due to similar 
conditions at the dispatch centre. The sample size calculation needs to account for correlation. 
Ideally   should be known prior to starting the survey, this quantity could be obtained either from 
pilot studies (as for the case of production areas, in which the CEFAS study was used as a pilot study 
to estimate the correlation) or based on expert opinion.  
Information regarding NoV presence in the French market (Schaeffer et. al., 2013) was used to 
obtain a proxy for the correlation between batches in a dispatch centre. The results obtained indicate 
that correlation among samples from the same establishment is likely to be very low (ranging from 0 
to 106). It should be noted that information on NoV presence in the French market was limited and 
the samples were taken largely from retailers rather than dispatch centres. Therefore, since no 
suitable pilot study is available, a multistage sampling scheme was used considering a similar 
correlation as the one found in production areas (0.30, upper bound), to be conservative. 
In order to keep the sampling process manageable and considering that the NoV levels are known to 
fluctuate across the year, the total number of batches to be sampled and the total number of 
samples to be taken from a production areas must be evenly distributed along the year. Therefore, 
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sampling with a bimonthly frequency (once sample every 2 months) is proposed for both production 
areas and dispatch centres.  
The final sample sizes can be calculated using equation (5), considering the cluster size ( ) to be 6 
(bimonthly visits by inspectors) and the correlation ( ) to be 0.30, upper bound estimate based on 
the CEFAS (2011) data from production areas. The resulting design effect will be 2.5, which should 
be further multiplied by the number of production areas or batches to be sampled when considering 
the simple random sampling scheme (358/385) producing the total number of samples to be taken 
for production areas and batches from dispatch centres.  
For the sample allocation per MS, there is a requirement to consider the possibility that during the 
survey there may be a failure to take or analyse a sample. For instance, adverse weather conditions, 
periods with no production in a dispatch centre, problems with sample transport and storage or an 
invalid analytical result. For this reason, it is necessary to inflate the sample size to ensure the 
required precision is achieved. For production areas where there should be oysters growing all year 
round, an inflation of 10% is applied. For dispatch centres, since consumption of oyster is seasonal, 
there may be months when oysters are not being packed and no sample can be taken, and for this 
reason, an inflation of 20% is applied. 
All calculations were rounded up in order to ensure the level of precision required. Table 2 indicates 
the number of locations to be visited and the number of samples to be taken annually per country.  
 
Figure 4:  Final fitted model (solid line) together with confidence band (grey shadow) for the fitted 
model and observed proportions bimonthly (red triangle) from CEFAS (2011). 
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Table 2:  Number of samples to be taken annually per country for production areas and dispatch 
centres (Considering bimonthly samples (once every 2 months) and the inflation for 
missing data)  
 Production area survey Approved dispatch centre survey 
Country Locations Total 
Samples 
Locations Total 
Batches 
Croatia 2 12 1 6 
Denmark 3 18 1 6 
France 74 444 167 1002 
Germany 1 6 1 6 
Greece 2 12 1 6 
Ireland 22 132 1 6 
Italy 7 42 9 54 
Netherlands 5 30 3 18 
Norway 2 12 0 0 
Portugal 5 30 2 12 
Spain 14 84 6 36 
Sweden 3 18 1 6 
United Kingdom 31 186 4 24 
Total 171 1026 197 1182 
 
2.1.4. Timing of the survey 
The result of any baseline survey presents a snapshot of the statistic of interest in the target 
population for the period when the survey was performed. Surveillance data from many countries 
indicates that there is annual variation in the number of NoV cases with peaks observed in years 
when pandemic strains emerge (laboratory reports confirming NoV from England and Wales, 6 
notifications and outbreaks data from Ireland,7 surveillance of acute diarrhoea in France8 and hospital 
data admissions from the USA (Hall et al, 2013)). In order to reduce the probability of 
surveying an atypical year, it is proposed to repeat the survey for a second year. 
Adjustments to the survey in the second year could be made, with agreement from the participating 
countries, to resolve issues identified in the first survey. 
The survey is to take place simultaneously at two points in the chain (production areas and 
dispatch centres) for a period of 2 years, with samples collected on a bimonthly basis (one sample 
every 2 months). The first samples are to be taken within the period 1 November–31 December 
2016. Since NoV prevalence is subject to temporal variability and the objective of the survey is to 
estimate the European prevalence, it is essential that all countries start the survey at the 
same time.  
2.1.5. Sampling Plan 
The CA for participating countries must nominate a national project manager for the baseline survey. 
The project manager is responsible for  
 preparation of a detailed survey plan; 
 the designation of one or more laboratories for NoV analysis in consultation with the CA and 
provide their contact details plus their field of analysis to the EURL; 
 the nomination of one or more data providers; 
                                                          
6   https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/492125/Norovirus_update_2015_week_53.pdf 
7   http://ndsc.newsweaver.ie/epiinsight/epq9pqq0uzsqldxs0g4hal?a=1&p=31757905&t=17517774 
8   https://websenti.u707.jussieu.fr/sentiweb/?page=serie 
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 development of/modification of existing sampling forms to be used by samplers; 
 coordination of the assignment of unique reference numbers for samples; 
 ensuring that the required numbers of samples are taken; 
 ensuring the survey results have been reported to EFSA. 
Prior to commencing the survey, the project manager should draft a detailed survey plan for their 
country. To assist in the preparation of the survey plan, EFSA will organise a workshop to which all 
participating countries will be invited. The workshop will focus on finalising country level sampling 
plans and training in the reporting of the survey results. 
In preparation for the workshop, EFSA will send out an excel file to each participating country which 
combines the information sent on classified production areas and approved dispatch centres to the 
EURL by May 2015 with the information on monthly batch production requested by EFSA in Nov 2015. 
These files are to be checked and updated prior to attending the workshop to ensure that the 
locations in the file match the target populations defined in Section 2.1.1. During the workshop, the 
files will be imported into a web-based tool to assist in the random selection of locations for inclusion 
in the survey according the survey design described in Section 2.1.3. 
Coordination of the selection of sampling locations is important to ensure that the samples taken are 
representative for European production areas and batches of final product and therefore ensuring 
that the European prevalence of NoV-contamination in production areas and batches of final product 
can be estimated with sufficient precision. 
The workshop will also provide the opportunity to discuss any operational issues and ensure that 
survey is a harmonised process in all participating countries.  
2.2. Sample collection 
2.2.1. Type and details of sample 
The CA considering the availability of samplers and oysters should plan the bimonthly (one sample 
every 2 months) sampling at the selected locations (dispatch centres and production areas). As far as 
possible, the locations should be visited on different days in the week and month over the period of 
the survey. However, consideration should also be given to the requirement for initial processing of 
the sample by the laboratory to be performed within 72 h of taking the sample, and for samples to 
arrive at the laboratory during the working week (from Monday to Friday). For example, sampling on 
Friday should be avoided without prior agreement with the laboratory. Additionally the locations 
within a geographical region visited at the same time should be varied. 
Where more than one oyster species (O. edulis, C. gigas, C. angulata) is present at the sample site a 
sample of only one oyster species is required for the survey.  
A sample of 15 live oysters should be taken and dispatched to the designated laboratory for pooled 
analysis for NoV. 
During sampling, precautions should be taken in order to avoid any activity that could affect the 
levels of viral contamination or result in a sample that is unsuitable for laboratory analysis.  
The oysters are to be placed in an intact food grade plastic bag or box (single use), securely 
packaged, and dispatched to the laboratory with a completed sampling form signed by the sampler 
and identified by a unique reference number (see Section 2.2.2). 
Representative sampling points within harvesting areas  
The production areas can be either natural beds or sites used for the cultivation of bivalve molluscs. 
In some production areas, there may be more than one commercial bivalve mollusc species present. 
In principle, it is necessary to discriminate between cultivated and wild molluscs, and to take into 
account the habitat where they grow (intertidal zone, sub tidal zone, benthic, water column, water 
surface) when selecting representative points.  
Regulation 854/2004 highlights the importance of choosing the sampling point/s in production areas 
based on a survey of faecal pollution inputs, although such information may not necessarily pre-exist 
for all areas particularly those classified before the applicability of this regulation. It has been 
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proposed that this information can form the initial basis for assessing the likely extent of NoV 
contamination of oysters in a harvesting area (Pommepuy and Le Guyader, 2008). EU guidance (EC 
2012) provides the possibility to identify one mollusc species as representative (indicator species) of 
the other ones present in the production area. 
For this baseline NoV survey, it is assumed that the oyster species (O. edulis, C. gigas and 
C. angulata) are similar in terms of filtration and there is a homogenous distribution of faecal 
contamination in the proximity of the pollution source between benthic zone and the water column.  
When obtaining a sample of oysters for the baseline NoV survey from a production area the following 
scenarios could occur: 
 One or more oyster species are present in the production area and no other molluscs are 
harvested for human consumption; the representative sampling point used for monitoring 
activities under Regulation 854/2004 can be used to obtain the sample of oysters. 
 More than one species is present in the production area and the oysters are the indicator 
species; the representative sampling point used for monitoring activities under Regulation 
854/2004 can be used to obtain the sample of oysters. 
 More than one species is present in the production area but oysters are not the indicator 
species.  
– If oysters are located in adequate proximity (as described in Section 3.5 of CEFAS, 
2014) to the representative sampling point then the representative sampling point 
used for monitoring activities under Regulation 854/2004 can be used to obtain the 
sample of oysters.  
– If the oysters are not located in adequate proximity to the representative sampling 
point is it necessary to identify and define a new sampling point within the area of 
oyster production that has the highest risk of faecal pollution based on the sanitary 
survey. The point must be fixed using the criteria reported in the EU guidance (EC 
2012) and should be used to obtain the sample of oysters. 
Where multiple representative sampling points are present in the same production area, the 
representative sampling point, where oyster species are present, with the highest levels of E. coli 
contamination based on the routine monitoring performed under Regulation 854/2004 should be 
used to obtain the sample of oysters. 
Oysters can be placed at the sampling point, at the direction of the CA, to facilitate sampling for the 
purposes of monitoring.  It is important that the oysters sampled, have been growing in the selected 
production area for more than 28 days, in order to be representative of this area and not a previous 
one.  
Samples are to be collected by samplers in parallel to the collection of samples for the microbiological 
monitoring programme, as specified by Regulation 854/2004. An additional sample of 15 live oysters 
is required for the baseline survey. 
Approved dispatch centres 
Oyster samples should be collected by samplers according to official controls procedures. The sample 
should be taken from one batch of live oysters present on the premises at the time of visit.  Fifteen 
oysters should be selected from the boxes on the packing line (representative of the sizes and grades 
of animals in the batch). The sample should not contain a mix of oyster species as this would not 
conform to the definition of a batch. It is acknowledged that 15 oysters may not be sufficient to 
detect NoV contamination in a batch, if the proportion of oysters contaminated is less than 20% 
(assuming test sensitivity greater than 90%). However, for countries with a large number of dispatch 
centres the number of oysters that can be processed by the laboratory daily is limited. In addition, 
there is the issue of the commercial value of oysters at this point in the food chain. 
The documents should be checked according to the record keeping requirements of Annex III, 
Section VII, Chapter I, and points 3 to 7 of Regulation (EC) No 853/2004 and special attention must 
be paid to the traceability records of the selected batch, from the Identification Mark back to the 
registration documents recording relaying or depuration records (if applicable). If the production 
area/s for the batch cannot be identified then the sample should not be taken.   
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2.2.2. Sample information 
For the purposes of the survey, each sample should have a unique reference number. This 
number should be used to ensure that the information collected by the sampler could be linked with 
all of the analytical results generated in the laboratory. This reference number is required for 
reporting data to EFSA and will be used for the subsequent data analysis. This number will also be 
used to calculate the number of samples performed per country upon completion of the survey. 
Depending on the data management systems in place in the country, this can be printed on the 
sample form or alternatively an identifier can be generated upon receipt of the sample at the 
laboratory.  
The principles for stipulating data to be recorded for this survey are as follows: 
 the information will be used for estimating the prevalence, or analysing the risk factors that 
might contribute to that prevalence; 
 the information should be readily obtainable by an official inspector. 
Production Area: The types of data that should be available regarding oysters taken from production 
areas are described in general in traceability requirements of Regulation (EC) No 178/20029 and its 
implementing regulation 931/2011.10  Oysters are also subject to the more specific requirements for 
all fishery and aquaculture products in the Fishery Control regulation 1224/200 11  and its 
implementing regulation 404/2011. 12   However, the key piece of legislation setting out the 
information that should be readily available for LBM coming from production areas is the Shellfish 
Registration Document required by Regulation (EC) No 853/2004.  Of particular note is the 
requirement for the classification status (based on E. coli monitoring results) of the production area 
to be indicated. 
Dispatch Centres: Batches of oysters from dispatch centres may comprise the products of several 
different production areas. Such food batches are subject to the general traceability and specific 
fishery control legislation in addition to Regulation (EC) No 853/2004. The general applicability of the 
Regulation 1169/201113 on Food Information to Consumers is also relevant at this stage. However, in 
the present context, the key piece of legislation is Regulation 1379/2013 14, which sets out the 
mandatory information that should be present on fishery and agriculture products when labelled for 
consumer sale or supply to mass caterers. Even if batches going from dispatch centres have not 
been labelled for such markets, they should be accompanied by such information in order to ensure 
accuracy of subsequent labelling. Labelling requirements are summarised in the EU Commission 
guide.15 Some provisions directly relevant to this programme include the mandatory requirement to 
provide catch area and catch method for wild-caught fish, and the provision of origin information for 
farmed fish, which in the case of farmed shellfish is the country in which it underwent a final rearing 
or cultivation stage of at least 6 months. 
A sample form to record the information listed below should be developed (examples of the sample 
forms are available in Appendix C.  
                                                          
9  Regulation (EC) No 178/2002 laying down the general principles and requirements of food law, establishing the European 
Food Safety Authority and laying down procedures in matters of food safety. 
10  Commission Implementing Regulation (EU) No 931/2011 on the traceability requirements set by Regulation (EC) No 
178/2002 of the European Parliament and of the Council for food of animal origin. 
11  Council Regulation (EC) No 1224/2009 establishing a Community control system for ensuring compliance with the rules of 
the common fisheries policy, amending Regulations (EC) No 847/96, (EC) No 2371/2002, (EC) No 811/2004, (EC) No 
768/2005, (EC) No 2115/2005, (EC) No 2166/2005, (EC) No 388/2006, (EC) No 509/2007, (EC) No 676/2007, (EC) No 
1098/2007, (EC) No 1300/2008, (EC) No 1342/2008 and repealing Regulations (EEC) No 2847/93, (EC) No 1627/94 and 
(EC) No 1966/2006. 
12  Commission Implementing Regulation (EU) No 404/2011 laying down detailed rules for the implementation of Council 
Regulation (EC) No 1224/2009 establishing a Community control system for ensuring compliance with the rules of the 
Common Fisheries Policy. 
13  Regulation (EU) No 1169/2011 on the provision of food information to consumers, amending Regulations (EC) No 
1924/2006 and (EC) No 1925/2006 of the European Parliament and of the Council, and repealing Commission Directive 
87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/EC, Directive 2000/13/EC of the European 
Parliament and of the Council, Commission Directives 2002/67/EC and 2008/5/EC and Commission Regulation (EC) No 
608/2004. 
14  Regulation (EU) No 1379/2013 on the common organisation of the markets in fishery and aquaculture products, amending 
Council Regulations (EC) No 1184/2006 and (EC) No 1224/2009 and repealing Council Regulation (EC) No 104/2000. 
15  http://trade.ec.europa.eu/doclib/docs/2014/december/tradoc_152941.pdf 
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Production Area Samples 
 sample reference number; 
 country: 
 production Area Code and/or Production Area name (Appendix D); 
 classification at time of sampling: 
– A, B or C (at time of sampling); 
– fully classified, Seasonal or Preliminary (optional); 
 sampling Date and Time 
 oyster species (O.  edulis, C.  gigas or C.  angulata) 
 sampling location (Longitude and latitude of representative sampling point (WGS84 format)): 
– intertidal – zone of shore between the high-water mark and the low-water mark; 
– or Inshore  < 5km from shore; 
– or Offshore  >= 5km from shore;  
 production information: 
– farmed or Wild; 
– production system: 
 raised trestle – bagged oysters grown on a raised structure (table, rack or 
trestle) installed on the substrate, on the foreshore;  
 or suspended from sea-surface – oysters are permanently immersed and 
suspended from tables or buoys using nets, caskets or ropes; 
 or bottom grown – oysters produced from existing oyster beds; 
 remarks, any unusual conditions at time of sampling or deviations from sampling plan; 
 sampler name (this is only required within the country in case of missing information and will 
not be reported to EFSA). 
Dispatch Centre Samples 
 sample reference number; 
 country; 
 dispatch centre approval number (Appendix D); 
 sampling date and time; 
 oyster species (O.  edulis, C.  gigas or C.  angulata); 
 overall batch weight (kgs); 
 overall batch origin (production area/s or catch area/s most representative of origin in terms 
of quantity (Articles 35 (3) of  Regulation (EC) 1379/2013); 
 number of production areas that contributed to sampled batch. 
For each contributing production area ‘lot’ of fish: 
– production Area Code and/or Production Area name (Appendix D), in case of relaying 
this should not be the relaying area code but the production area code prior to 
relaying; 
– classification of production area as indicated in traceability documents: 
 A, B or C; 
– date of harvesting; 
– indicate if any of the following activities or treatments have been applied to the 
oysters in the batch and the duration: 
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 conditioning; 
 relaying; 
 purification:  
o If purified describe conditions: 
 Ambient, actively heated, actively cooled or Unknown 
 Temperature (°C) 
– indicate if the oysters are wild or farmed: 
 If farmed, origin as defined by Regulation 1379/2013 Article 38 1(c). 
Country in which the oysters underwent a final rearing or cultivation of at 
least 6 months 
 If wild, at least FAO area code or more accurate indicator of origin, e.g. 
country coastal waters, and whether the oysters were hand-picked, raked or 
dredged 
 Record if the batch contains oysters that have already been assigned an Identification Mark 
in cases where the dispatch centre is performing mixing of splitting activities 
 Remarks, any unusual conditions at time of sampling or deviations from sampling plan 
 Sampler name (this is only required within the country in case of missing information and will 
not be reported to EFSA) 
2.2.3. Sample transport 
Sample transport from both production areas and dispatch centres must be carried out in accordance 
with the requirements laid out in Section 4 of CEFAS (2014) with the exception that the maximum 
time permitted between sample collection and the initiation of sample processing is 72 h. For this 
reason, the time of sampling must be recorded on the sample form. When taking samples it is 
important to consider that samples should arrive at the laboratory during the working week.  
2.3. Laboratory analysis 
2.3.1. Participating laboratories 
The baseline survey is envisaged as a formal activity of CA falling under their Official Control 
responsibilities. Therefore, the working group has reviewed the usual requirements for Official 
Control sampling and analysis as set out in Regulation 882/200416 for applicability to this baseline 
survey.  
Designation of laboratories: To ensure laboratories are under the responsibility of the CA, EU 
Regulation 882/2004 requires them to be formally designated by the CA. Therefore, the CA in each 
country must designate the laboratories undertaking NoV analysis for this survey. The designated 
laboratories can perform one or more of the following steps described in the EURL method 
specification (Appendix B); sample preparation, virus extraction, RNA extraction, PCR detection, PCR 
quantification or sample archiving. 
The following conditions apply to designated laboratories:  
 a protocol must be prepared for the analysis the laboratory will perform in the survey. If 
more than one laboratory is involved in producing an analytical result, the protocol(s) must 
describe the parts undertaken by each laboratory, the conditions for transport of processed 
samples between laboratories, and any necessary breakpoints, etc. Protocol(s) must be in 
conformity with the method specification in Appendix B and must be approved by the 
National Reference Laboratory (NRL). Protocol(s) covering the entire analytical procedure 
must form an annex of the survey plan prepared by the project manager; 
 the laboratory does not need to be accredited for ISO/DIS 15216-1; however, laboratories 
undertaking quantification must be able to report an LOQ for the NoV PCR. For 
laboratories requiring assistance, approaches to establishing an LOQ will be covered as part 
of the optional EURL training (detailed below); 
                                                          
16  Regulation (EC) No 882/2004 on official controls performed to ensure the verification of compliance with feed and food 
law, animal health and animal welfare rules. 
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 the laboratories performing NoV quantification must participate in the EURL proficiency test. 
Laboratories undertaking other aspects of the method should participate in proficiency 
testing organised by their NRL.    
Supervision by the NRL: To ensure harmonised analysis at the EU level, Regulation 882/2004 sets 
out the responsibilities of NRLs for supervision of Official Control laboratories. It is proposed to adopt 
the same approach for this survey – designated laboratories must be supervised by the NRL of that 
MS. This requirement is not necessary if the designated laboratory is the NRL. Following designation, 
the EURL will contact all laboratories designated for NoV analysis, and supervising NRLs to further 
discuss training and analysis. For laboratories not performing PCR quantification, as part of the 
supervisory role of the NRL, the NRL may organise training and local proficiency tests to ensure the 
necessary standards can be achieved by these laboratories. 
Training: NoV analysis is complex and proficiency testing clearly demonstrates the potential for 
significant deviation of results between laboratories following analysis of the same distributed sample. 
It is considered essential for this harmonised survey that a high level of confidence can be ascribed 
to the comparability between laboratories for results of NoV analysis (both qualitative and 
quantitative). EURL proficiency testing clearly demonstrates that robust confidence in analytical 
comparability is best achieved through the adoption of harmonised analytical methods and by 
ensuring laboratory competence. To assist the adoption of harmonised procedures, and to reinforce 
competence, the EURL will offer an EC funded 4-day training course open to at least one technician 
from all designated laboratories undertaking analysis of NoV for this survey. This training is not 
mandatory. The NRLs may also organise a similar training for technicians from the designated 
laboratories within their country.  
Competence assessment: Following the above training, and for those laboratories undertaking 
quantification, the EURL will organise a proficiency test round to assess laboratory competence. 
Where analysis is split between laboratories, NRLs should also perform proficiency testing to ensure 
competence in all parts of the method. Laboratories will be given additional support by the NRL and 
EURL in case of the requirement of a repeat of the proficiency test. To participate in the NoV PCR 
quantification for the survey, it will be necessary to demonstrate satisfactory performance in 
proficiency testing. 
2.3.2. Analytical method 
The analysis of NoV in oysters by all laboratories will be performed according to the method 
specification developed by the EURL expert working group specifically for this study (Appendix B). 
The survey requires separate real-time reverse transcription (RT)-PCR analysis for NoV genogroup I 
(GI) and NoV genogroup II (GII). This method specification sets out the procedures that designated 
laboratories are required to follow in performing analysis of oysters submitted under this survey. The 
specification is based on, and is compliant with, ISO/DIS 15216-1; Microbiology of the food chain -- 
Horizontal method for determination of hepatitis A virus and NoV in food using real-time RT-PCR -- 
Part 1: Method for quantification (the draft revision to the ISO method including validation data, due 
for publication in 2016). Accordingly, there are some differences to the current published technical 
specification ISO/TS 15216-1:2013. The method specification has been compiled and agreed by the 
EURL technical working group comprised of representatives from the EURL and EFSA, and NRLs of 
France, Ireland, Germany, Denmark and Italy.  
Use of the procedures in compliance with the method specification will be mandatory for all 
laboratories participating in NoV analysis in the study. The MS NRL will supervise analysis in the 
designated laboratories and will be responsible for ensuring compliance with the protocol. Upon 
request, control materials can be provided to the participating laboratories by the EURL. 
2.3.3. Storage of samples 
All RNA extracts should be stored as described in the method specification (Appendix B). This would 
allow reanalysis in case of reagent or standard failures or other issues related to the estimation of 
NoV copy number.  
It is proposed to archive all samples collected during this project to facilitate further research (e.g. 
NoV whole genome sequencing, analysis for presence/absence of hepatitis A virus). Once the 
analytical result has been confirmed the digestive glands, supernatant and RNA should be stored        
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at -700C or below. These samples should be stored at a single location in each country, either the 
NRL or another laboratory with suitable archiving facilities. The samples should be stored for a 
minimum of 2 years after the survey has been completed. The unique reference number used in 
the survey must be linked to all of the stored samples so that the survey data can also be used in 
further research efforts. 
Researchers wishing to make use of the baseline survey sample archive must present their research 
proposals to the Standing Committee on Plants, Animals, Food and Feed (PAFF Committee). They 
must seek permission for the use of the samples in the archive from the relevant countries holding 
the samples from the PAFF Committee. These proposals must be made within 1 year from the 
completion date of the survey, and the research should be performed within the following year. 
Priority for use of the samples will be given to European research proposals; however, the remaining 
materials can be used for national research initiatives.  
2.4. Reporting 
The national project manager should nominate one or more data providers responsible for the 
submission of the results of the baseline survey to EFSA and the European Commission. The data 
providers can be staff from the nominated laboratories, the CA or other agencies with a responsibility 
for microbiological monitoring of LBM; however, where there are multiple data providers the survey 
project manager should ensure that the reporting is consistent within the country. 
The nominated data providers will be provided with instruction manuals and training in the 
preparation and submission of the data by EFSA. The nominated data providers will be the contact 
points in case of data validation and data quality queries.   
It is essential that sample forms are checked for completion and all the information on the form is 
entered correctly into the local data management system. 
2.4.1. Data model 
EFSA Standard Sample Description version 2.0 (EFSA, 2013b) is designed to allow the reporting of 
laboratory results that are comparable between laboratories and countries. The reporting of the 
baseline survey results will use this data model as the basis with extensions to support the analysis 
of the results of the baseline survey (Table 3 and 4). The application of controlled terminology 
ensures that the reporting of results is harmonised and comparable between countries. The 
Controlled Terminology column of Table 3 and 4 indicates those variables where a controlled 
terminology is applied. Where a limited number of terms can be selected, the codes or terms to be 
used are specified in full and in cases where a longer list of terms can be selected (e.g. country of 
origin), the catalogue names are listed (underlined). These catalogues are published on the EFSA 
website.17  
In the tables below, the variables to be reported for each laboratory result are described. A unique 
identifier (resID) is required for each row within the dataset. One row represents a single analytical 
result linked to a description of the sample of oysters. There can be more than one analytical result 
for each oyster sample; therefore, the unique reference number (sampID) must be the same for all 
analytical results for that sample of oysters. The quantitative results and results below limit of 
detection (LOD)/LOQ for both genotype I and genotype II must be reported for all samples taken. If 
it is not possible to analyse the sample or a valid laboratory result cannot be obtained the reason for 
this failure should be recorded. 
  
                                                          
17   http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/3424.pdf 
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Table 3:  Production areas: Description of variables to be reported for the survey 
Element Name Data Type M(a) Controlled terminology Description 
progId xs:string (100) Y EU baseline survey of 
norovirus in oysters 
Name of survey 
progLegalRef xs:string (5) Y LEGREF Reference to published 
Commission Decision concerning 
financial contribution 
sampStrategy xs:string (5) Y ST10A = Objective sampling 
(SRS) 
Description of the sampling 
methodology 
progType xs:string (5) Y K027A = Survey - EU baseline 
survey 
Type of programme for which the 
samples have been collected 
sampPoint xs:string (5)  Y E150A = Production areas 
 
Specify that the sample came 
from a production area 
sampId xs:string (100) Y  The unique reference number 
for the sample, this must be 
maintained when reporting all 
laboratory results linked to the 
sample 
See Section 2.2.2 
sampUnitType xs:string (5) Y G198A = holding/production 
area 
Description of the sampling unit 
sampUnitSize xs:double Y  Mean animal weight in sample 
(entire animal including shell)  
sample weight/number of oysters 
sampUnitSizeUnit xs:string (5) Y G167A = grams Units for the value reported in 
sampSizeUnit 
sampHoldingId xs:string (250) Y Production area code list in 
(Appendix D) 
Site identifier for the production 
area the sampled oysters came 
from  
areaStatus xs:string (5) Y A / B / C Classification of the production 
area at time of sampling 
classType xs:string (250)  Fully classified / Seasonal / 
Preliminary 
Type of classification applied for 
the areaStatus reported above 
areaType xs:string (250) Y Intertidal / Inshore / Offshore 
/ Unknown 
Type of oyster production area 
production xs:string (250) Y Wild / Farmed / Unknown Indicate if the oysters are wild or 
farmed  
productionsystem xs:string (250) Y Raised Trestle / Suspended 
from sea-surface / Bottom-
grown / Unknown 
Description of the oyster 
production system  
sampCountry xs:string (2) Y COUNTRY Country where the sample was 
taken for laboratory testing (ISO 
3166-1-alpha-2)  
longitude xs:string (20)   Longitude of the location of the 
representative sampling point 
where the sample was taken in 
WGS84 format 
latitude xs:string (20)   Latitude of the location of the 
representative sampling point 
where the sample was taken in 
WGS84 format 
sampY xs:integer (4) Y  Year of sample 
sampM xs:integer (2) Y  Month of sample 
sampD xs:integer (2) Y  Day of sample 
sampT xs:integer (2)   Hour of sampling in 24-h format 
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Element Name Data Type M(a) Controlled terminology Description 
sampInfo xs:string (250)   Report any remarks recorded at 
the time of sampling 
arrivalD xs:integer (2)   Day of arrival in the lab 
arrivalT xs:integer (2)   Hour of arrival in the laboratory in 
24-h format 
arrivalTemp xs:double Y  Sample temperature at time of 
arrival in the lab in Centigrade 
sampMatType xs:string (5) Y S019A = Food sample Type of sample taken 
sampMatCode xs:string (400) Y A055F = Ostrea edulis 
A055J = Crassostrea gigas 
A02HK = Crassostrea angulata 
 
Species of oyster sampled 
sampMatText xs:string (250)   Optional description of the 
characteristics of the sample 
taken using free text 
origFishAreaCode xs:string (10) Y FAREA Fisheries or aquaculture area 
specifying the origin of the sample 
(FAO Fisheries areas) at the level 
of FAO Sub Area 
sampAnId xs:string (100)    Identification code of the 
analysed sample, by default the 
same as the sampId. Used when 
the sample is split into analysis 
portions for the same analytical 
measurement, in this case 
sampID plus incremental number 
analysisY xs:integer (4)  Y  Year when the analysis was 
completed 
analysisM xs:integer (2) Y  Month when the analysis was 
completed 
analysisD xs:integer (2) Y  Day when the analysis was 
completed 
labId xs:string (50)   Y  Identification code of the 
laboratory to be contacted in case 
of questions about the result 
(National laboratory code if 
available). This code should be 
nationally unique and consistent 
through all data domain 
transmissions.  
NRL xs:string (1)  Y Y / N Is the laboratory the national 
reference laboratory 
labCountry xs:string (2) Y COUNTRY Country where the laboratory is 
located (ISO 3166-1-alpha-2). 
paramCode xs:string (400) Y RF-00003060-PAR = Norovirus 
GI 
RF-00003061-PAR = Norovirus 
GII 
Analysis for which microorganism. 
For each sample the results for 
both norovirus GI and GII should 
be reported as separate rows 
paramText xs:string (250)   Description of the parameter/ 
analyte using free text 
anMethRefCode xs:string (5)  Y R023A = CEN ISO TS 15216-
1:2013 
Code to identify the analytical 
method used 
anMethText xs:string (250)   Description of the method if any 
deviation from the validated 
method occurred 
resId xs:string (100)  Y  Identification code of an analytical 
result (a row of the data table) in 
the transmitted file. The result 
identification code must be 
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Element Name Data Type M(a) Controlled terminology Description 
maintained at organisation level 
and it will be used in further 
updated/deletion operation from 
the senders. 
accredProc xs:string (5)   V001A = Accredited according 
to ISO/IEC17025 
V005A = Internally validated 
V999A = Not validated 
The accreditation status of the 
analytical method  
resUnit xs:string (5) Y Detectable virus genome 
copies per g 
Unit of measurement the result 
value 
resLOD xs:double   Report the limit of detection  
resLOQ xs:double Y  Report the limit of quantification 
resVal xs:double   The quantitative result not 
censored according to the LOQ; 
Detectable norovirus genome 
copies per g 
resQualValue xs:string (3)  POS = positive 
NEG = not detected 
Report the qualitative result of the 
laboratory analysis 
resType xs:string (3)   VAL =sample is quantifiable 
LOQ = sample is not 
quantifiable 
For positive results, indicate 
whether the sample is quantifiable 
or not quantifiable 
resValUncert xs:double   Indicate uncertainty of 
measurement  
log 10 copies/g for QPCR 
resValUncertSD xs:double   Standard deviation for the 
uncertainty of measurement. 
resStatus xs:string (50) Y Valid / Not valid/ Not tested Each sample collected should be 
reported  
Select ‘Not Tested’ if the sample 
was rejected for laboratory testing  
Select ‘Not Valid’ if no laboratory 
result could be obtained following 
retesting 
resInfo xs:string (250)   Where resStatus is not valid 
report the reason quantification of 
NoV could not be achieved 
(a): ‘Y’ indicates this element is mandatory and must be completed 
 
Table 4:  Dispatch centres: Description of variables to be reported for the survey 
Element Name Type M(a) Controlled terminology Description 
progId xs:string (100) Y EU baseline survey of norovirus 
in oysters 
Name of survey 
progLegalRef xs:string (5) Y LEGREF Reference to published 
Commission Decision 
concerning financial 
contribution 
sampStrategy xs:string (5) Y ST10A = Objective sampling Description of the sampling 
methodology 
progType xs:string (5) Y K027A = Survey - EU baseline 
survey 
Type of programme for which 
the samples have been 
collected 
sampPoint xs:string (5)  Y E320A = Approved dispatch 
centre 
 
Specify that the sample came 
from a dispatch centre 
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Element Name Type M(a) Controlled terminology Description 
sampId xs:string (100) Y  The unique reference 
number for the sample, this 
must be maintained when 
reporting all laboratory results 
linked to the sample 
See Section 2.2.2 
sampUnitType xs:string (5) Y G204A = batch Description of the sampling unit 
sampUnitSize xs:double Y  Overall batch weight 
sampUnitSizeUnit xs:string (5) Y G167A = kilograms  Units for the value reported in 
sampSizeUnit 
sampPlantId xs:string (250) Y Dispatch centre code list in 
(Appendix D) 
Dispatch Centre Approval 
Number the sampled 
consignment came from 
batchId xs:string (250) Y  Report the unique identifier of 
the batch from the internal 
traceability system 
sampHoldingId xs:string (250) Y Production area code list in 
(Appendix D) 
Site identifier for the production 
areas the sampled oysters came 
from. Where a batch is 
composed of oysters from more 
than one production area the 
codes should be listed separated 
by a ‘$’ 
nProductionAreas xs:integer (4) Y  Report the number of 
production areas the oysters in 
batch came from 
areaStatus xs:string (5)  A / B / C Classification of the production 
areas that were the source of 
the batch 
Where a batch is composed of 
oysters from different 
production areas,  the area 
statuses should be listed 
separated by a ‘$’ 
production xs:string (250) Y Wild / Farmed / Unknown Indicate if the oysters are wild 
or farmed 
repacked xs:string (1) Y Y / N / U Indicate if any oysters within the 
batch have already been 
assigned with an Identification 
Mark – i.e. the dispatch centre is 
performing mixing or splitting 
activities 
sampCountry xs:string (2) Y COUNTRY Country where the sample was 
taken for laboratory testing 
(ISO 3166-1-alpha-2).  
sampY xs:integer (4) Y  Year of sample 
sampM xs:integer (2) Y  Month of sample 
sampD xs:integer (2) Y  Day of sample 
sampT xs:integer (2)   Hour of sampling in 24-h format 
sampInfo xs:string (250)   Report any remarks recorded at 
the time of sampling including 
any issues related to the 
traceability documentation 
arrivalD xs:integer (2)   Day of arrival in the lab 
arrivalT xs:integer (2)   Hour of arrival in the laboratory 
in 24-h format 
arrivalTemp xs:double Y  Sample temperature at time of 
arrival in the lab in Centigrade 
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Element Name Type M(a) Controlled terminology Description 
sampMatType xs:string (5) Y S019A = Food sample Type of sample taken 
sampMatCode xs:string (400) Y A055F = Ostrea edulis 
A055J = Crassostrea gigas 
A02HK = Crassostrea angulata 
Species of oyster sampled 
sampMatText xs:string (250)   Optional description of the 
characteristics of the sample 
taken using free text. 
durCondition double Y  Report the duration of 
conditioning applied to oysters 
in the batch in hours 
0 indicates the batch has not be 
subjected to conditioning 
-9999 indicates it is not known 
if the batch has been subjected 
to conditioning 
durRelaying double Y  Report the duration of relaying 
applied to oysters in the batch 
in days 
0 indicates the batch has not be 
subjected to relaying 
-9999 indicates it is not known 
if the batch has been subjected 
to relaying 
durPurification double Y  Report the duration of 
purification applied to oysters in 
the batch in hours 
0 indicates the batch has not be 
subjected to purification 
-9999 indicates it is not known 
if the batch has been subjected 
to purification 
condPurification xs:string (250)  Ambient / Actively heated / 
Actively cooled / Unknown 
Report the thermal status of the 
water used for purification if 
purification has occurred 
purificationTemp xs:double   Temperature of water in 
purification tank in Centigrade if 
purification occurred 
origCountry xs:string (2)  COUNTRY Overall Batch Origin (production 
area/s or catch area/s most 
representative of origin in terms 
of quantity (Articles 35 (3) of  
Regulation (EC) 1379/2013) 
origFishAreaCode xs:string (10)  FAREA For wild oysters, report the 
origin of the sample using at 
the level of FAO sub area 
origFishAreaText xs:string (250)   Name of the fishing area 
specified on the label. Where a 
batch is composed of oysters 
from more than one area the 
names should be listed 
separated by a ‘$’ 
fishMethod xs:string (250)  hand-picked / raked / dredged / 
unknown 
Fishing method used to obtain 
oyster batch for wild oysters 
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Element Name Type M(a) Controlled terminology Description 
procCountry xs:string (50)  COUNTRY If farmed, origin As defined by 
Regulation 1379/2013 Article 38 
1. (c). Country in which the 
oysters underwent a final 
rearing or cultivation of at least 
6 months. Where a batch is 
composed of oysters from more 
than one country the codes 
should be listed separated by a 
‘$’ 
prodY xs:string (4)   Year of harvesting of the 
oysters included in the batch 
prodM xs:string (10)   Month of harvesting of the 
oysters included in the batch. If 
there are different harvesting 
months (oysters from more 
than source) the months should 
be listed separated by a ‘$’ 
prodD xs:string (10)   Day of harvesting of the oysters 
included in the batch. 
If there are different harvesting 
days (oysters from more than 
source) the days should be 
listed separated by a ‘$’ 
sampAnId xs:string (100)    Identification code of the 
analysed sample, by default the 
same as the sampId. Used 
when the sample is split into 
analysis portions for the same 
analytical measurement, in this 
case sampID plus incremental 
number 
sampSize xs:double Y     
sampSizeUnit xs:string (5) Y G167A = grams Units for the value reported in 
sampSize 
analysisY xs:integer (4)  Y  Year when the analysis was 
completed. 
analysisM xs:integer (2) Y  Month when the analysis was 
completed. 
analysisD xs:integer (2) Y  Day when the analysis was 
completed. 
labId xs:string (50)   Y  Identification code of the 
laboratory (National laboratory 
code if available). This code 
should be nationally unique and 
consistent through all data 
domain transmissions. 
NRL xs:string (1)  Y Y / N Is the laboratory the national 
reference laboratory 
labCountry xs:string (2) Y COUNTRY Country where the laboratory is 
located (ISO 3166-1-alpha-2). 
paramCode xs:string (400) Y RF-00003060-PAR = Norovirus 
GI 
RF-00003061-PAR =Norovirus 
GII 
 
Analysis for which 
microorganism. For each 
sample, the results for both 
norovirus GI and GII should be 
reported as separate rows. 
paramText xs:string (250)   Description of the parameter/ 
analyte using free text 
anMethRefCode xs:string (5)  Y R023A = CEN ISO TS 15216-
1:2013 
Code to identify the analytical 
method used 
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Element Name Type M(a) Controlled terminology Description 
anMethText xs:string (250)   Description of the method if any 
deviation from the validated 
method occurred 
resId xs:string (100)  Y  Identification code of an 
analytical result (a row of the 
data table) in the transmitted 
file. The result identification 
code must be maintained at 
organisation level and it will be 
used in further 
updated/deletion operation 
from the senders. 
accredProc xs:string (5)   V001A = Accredited according to 
ISO/IEC17025 
V005A = Internally validated 
V999A = Not validated 
The accreditation status of the 
analytical method  
resUnit xs:string (5) Y Detectable virus genome copies 
per g 
Unit of measurement the result 
value 
resLOD xs:double   Report the limit of detection  
resLOQ xs:double Y  Report the limit of 
quantification 
resVal xs:double   The quantitative result not 
censored according to the LOQ;  
Detectable norovirus genome 
copies/g 
resQualValue xs:string (3)  POS = positive 
NEG = not detected 
Report the qualitative result of 
the laboratory analysis 
resType xs:string (3)   VAL =sample is quantifiable 
LOQ = sample is not quantifiable 
For positive results, indicate 
whether the sample is 
quantifiable or not quantifiable 
resValUncert xs:double   Indicate uncertainty of 
measurement  
log 10 copies/g for QPCR 
resValUncertSD xs:double   Standard deviation for the 
uncertainty of measurement 
resStatus xs:string (50) Y Valid / Not valid/ Not tested Each sample collected should 
be reported  
Select ‘Not Tested’ if the sample 
was rejected for laboratory 
testing  
Select ‘Not Valid’ if no 
laboratory result could be 
obtained following retesting 
resInfo xs:string (250)   Where resStatus is not valid 
report the reason quantification 
of NoV could not be achieved 
(a): ‘Y’ indicates this element is mandatory and must be completed 
2.4.2. Business rules 
The submitted data will be checked to ensure that the mandatory elements (Column M in Tables 3 
and 4) are completed, the correct data type is used and for compliance with the controlled 
terminologies. In addition, checks between elements will be made for consistency and plausibility. 
The checks are listed in Table 5 including a description of the business rule code and message 
reported in case a record fails the business rule checks. If the submitted data set fails, one or more 
of the checks the data set is rejected. A report listing the identified errors will be sent to the data 
provider with advice on required modifications. The data provider must resubmit the data until the 
data set passes the validation checks and is marked as ‘Valid’. 
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Table 5:  Business rules for reporting baseline survey results 
Description Elements Info Type Business 
rule code 
Info Message 
‘Year of analysis’ has to 
be less than or equal to 
the current year 
analysisY$<=$nowY E ER1 Analysis year cannot be 
greater than the current 
year 
The ‘area of sampling’ 
reported must be 
included in the country 
reported in ‘Country of 
sampling’ 
sampArea$sampCountry E ER4 The sampling area must 
be within the sampling 
Country 
‘Year of sampling’ must 
be less or equal to the 
current year 
sampY$<=$nowY E ER5 Sample year cannot be 
greater than the current 
year 
‘Year of sampling’ must 
be less than or equal to 
‘year of analysis’ 
sampY$<=$analysisY E ER6 Sample year cannot be 
greater than the 
analysis year 
‘Month of sampling’ has 
to be filled in if ‘Day of 
sampling’ is filled in 
sampM$sampD E ER8 Sample month must be 
completed if sample day 
is completed 
The partial date 
sampM/sampY must be 
less or equal to the 
current partial date M/Y 
sampM$sampY$<=$nowM
$nowY 
E ER9 The combination of 
sample month and 
sample year must be 
less than or equal to the 
current month and year 
The partial date 
sampM/sampY must be 
less or equal to the 
partial date 
analysisM/analysisY 
sampM$sampY$<=$analysi
sM$analysisY 
E ER10 The combination of 
sample month and 
sample year must be 
less than or equal to the 
analysis month and year 
The date 
sampD/sampM/sampY 
must be a valid date 
sampD$sampM$sampY E ER12 The combination of 
sample day, month and 
year must be a valid date 
The date 
sampD/sampM/sampY 
must be less or equal to 
the current date D/M/Y 
sampD$sampM$sampY$<
=$nowD$nowM$nowY 
E ER13 The combination of 
sample day, month and 
year must be less than or 
equal to the current date 
The date 
sampD/sampM/sampY 
must be less or equal to 
the current date 
analysisD/analysisM/anal
ysisY 
sampD$sampM$sampY$<
=$analysisD$analysisM$an
alysisY 
E ER14 The combination of 
sample day, month and 
year must be less than 
or equal to the analysis 
day, month and year 
Where resType = "VAL"  
then resVal must be 
provided 
resVal$resType$=$"VAL" E ER15 The result value must 
be completed if the 
sample is quantifiable 
Where resQualValue = 
"POS"  then resType 
must be provided 
resType$resQualValue$=$"
POS" 
E ER16 The result type must be 
completed if the sample 
is reported as positive 
Where resStatus = 
"Valid"  then 
resQualValue must be 
provided 
resQualValue$resStatus$=
$"Valid" 
E ER17 If the laboratory result 
is valid then the 
qualitative result must 
be reported 
Where durPurification > 
0 then condPurification 
must be provided 
condPurification $ Not 
Tested $>$0 
E ER18 The purification 
conditions must be 
reported when the 
duration of purification 
(durPurification) is 
greater than 0  
Where resStatus = "Not 
Tested"  then resInfo 
must be provided 
resInfo$resStatus$=$" Not 
Tested" 
E ER19 The resInfo must be 
completed if resStatus is 
‘Not tested’  
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Description Elements Info Type Business 
rule code 
Info Message 
Where resStatus = "Not 
Valid"  then resInfo must 
be provided 
resInfo$resStatus$=$" Not 
Valid" 
E ER20 The resInfo must be 
completed if resStatus is 
‘Not Valid’  
Where production = 
"Wild"  then fishMethod 
must be provided 
fishMethod$production$=$
"Wild" 
E ER21 The fishMethod must be 
completed if production 
is ‘Wild’  for batches 
from dispatch centres 
Where production = 
"Wild"  then 
origFishAreaText must 
be provided 
origFishAreaText$productio
n$=$"Wild" 
E ER22 The origFishAreaText 
must be completed if 
production is ‘Wild’  for 
batches from dispatch 
centres 
Where production = 
"Wild"  then 
origFishAreaCode must 
be provided 
origFishAreaCode$producti
on$=$"Wild" 
E ER23 The origFishAreaCode 
must be completed if 
production is ‘Wild’  for 
batches from dispatch 
centres 
Where production = 
"Farmed"  then 
procCountry must be 
provided 
procCountry$production$=
$"Farmed" 
E ER24 The country where the 
oysters underwent final 
rearing must be 
reported if production is 
‘Farmed’  for batches  
from dispatch centres 
‘Mean weight of oysters’ 
must be less or equal to 
the 250 
sampUnitSize $<=250 E ER25 The mean weight of the 
oysters samples cannot 
be greater than 250 g 
2.4.3. Submission to Data Collection Framework 
The data should be reported via the EFSA data collection framework (DCF).18 Data received by the 
EFSA DCF will go through automated validation processes for data elements, controlled terminology 
values, and general and specific business rules (described in Section 2.4.2). Messages regarding the 
status of the transmission will be exchanged with the data provider. 
The format for data submission is Extensible markup language (XML). 19 EFSA will provide excel 
templates to assist in the compilation of the results of the baseline survey and facilitate the export of 
the data into XML format. The use of the templates is not mandatory; data providers can chose to 
use their own data management systems to output the results in the required XML format. The XML 
schema definitions20 describing the required XML format are available in Appendix D. 
The available results of laboratory testing performed for the baseline survey should be reported on a 
quarterly (every 3 months) basis. Where RNA extracts are stored prior to batch laboratory analysis, 
the results for all samples within the batch should be reported as soon as the real-time RT-PCR 
quantification is completed. This will allow early validation of the data to ensure that the problems 
related to missing data can be resolved in a timely fashion and to allow an assessment of the 
conformity of the available results with the sampling plan. 
2.4.4. Member state reports 
Upon receipt of a valid quarterly submission of data for the baseline survey, a summary report of the 
results will be sent by e-mail to the data provider. This will allow the data provider to confirm that 
the information submitted has been correctly received by EFSA. If requested, the report can also be 
sent to the NRL for confirmation of the submitted laboratory results. The report will include the 
following tables: 
 number of samples taken by production area and month of sampling; 
 number of samples taken by dispatch centre and month of sampling; 
                                                          
18   https://dcf.efsa.europa.eu/dcf-war/dc  
19   http://www.w3.org/XML/  
20   http://www.w3.org/TR/xmlschema11-1/  
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 number of samples by production area, production system descriptors and species sampled; 
 number of samples by dispatch centre, production and treatment information and species 
sampled; 
 number of samples below LOQ and minimum, maximum, median and mean detectable 
genome copies for samples above LOQ for production areas NoV by genotype and for total 
NoV; 
 number of samples below LOQ and minimum, maximum, median and mean detectable 
genome copies for samples above LOQ for dispatch centres by NoV genotype and for total 
NoV; 
 proportion of samples < LOQ, 100, 200, 500, 1,000, 5,000, 10,000 and > 10,000 copies/g by 
production area classification and month of sampling; 
 proportion of samples from batches < LOQ, 100, 200, 500, 1,000, 5,000, 10,000 and 
> 10,000 copies/gram by production area classification as indicated in traceability documents 
and month of sampling. 
2.4.5. Production volumes 
For the analysis of the baseline survey results, there is a requirement to adjust the reported results 
for batches by the production volumes in Europe for the duration of the survey.  In order to obtain 
this data, the following information on production volumes should be submitted to the DCF upon 
completion of the survey. This information should be collected from all dispatch centres (not only 
those sampled) in each country. 
Table 6:  Description of variables to be reported for production volumes 
Element 
Name 
Data 
Type 
M(a) Controlled terminology Description 
PlantId xs:string 
(250) 
Y Dispatch centre code 
(Appendix D) 
Dispatch Centre Approval Number for the 
source of the batches 
Country xs:string 
(2) 
Y COUNTRY Country where the dispatch centre is 
located 
Y xs:integer 
(4) 
Y  Year of production 
M xs:integer 
(2) 
Y  Month of production 
batch xs:integer 
(30) 
Y  Number of batches produced in the 
dispatch centre in the month reported 
above 
tonnage xs:double   Production volume for the dispatch centre 
in the month reported above in kilograms 
(a): ‘Y’ indicates this element is mandatory and must be completed 
2.5. Plan of analysis 
In order to provide a general description of the collected data in terms of sample size, a table 
containing the planned and achieved sample size for each country participating in the survey will be 
prepared for production areas and dispatch centres. 
Exploratory analysis of all data collected will be carried out, considering simple statistics, such as 
mean, standard deviation, frequency tables, and graphs in order to provide a general overview of the 
data submitted.  
Generalized linear (mixed) models will be fitted depending on the population structure to be analysed 
to estimate proportion of sample units as previously defined above the following thresholds (< LOQ, 
100, 200, 500, 1,000, 5,000, 10,000 and > 10,000 copies/g) as well as 95% confidence intervals, 
considered as primary endpoint. Proportions will only be presented at a European level; no country 
specific analysis is planned.  
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The same type of model will be extended and used to estimate the potential effect of countries, time 
of sampling, norovirus genotype, classification of the production area (categories A, B and C) and 
other potential risk factors that could influence the proportion of sample units above the prespecified 
number of copies threshold. The obtained results will be shown using graphs, tables-containing 
estimated values of the parameters as well as standard error and significance level.  
As the primary objective of the survey is not to assess specific risk factors effects, 
sparseness/separation could be an issue when carrying out the analysis. Ensoy et. al (2015) 
proposed a structure and harmonised guidance on how to deal with such issues, depending on the 
type of analysis performed, this will be used when analysing the Nov baseline survey data. Figure 5 
presents the strategy that will be followed to deal with such issues.  
Survival models considering censoring of the number of copies (considered as secondary endpoint) 
reported will be explored accounting for the risk factors previously mentioned. The distribution of 
number of copies at EU level will be fitted considering the nature of the outcome (log-normal, 
Gamma, Weibull, Exponential, etc.). The resulting best-fitted distribution can then be used to 
estimate the number of sample units below specific thresholds of number of copies. 
 
Figure 5: Decision tree for analysis of NoV baseline survey data in case of separation issues Ensoy 
et. al. (2015) 
 
  
Survey of norovirus in oysters 
 
 
 
 
www.efsa.europa.eu/efsajournal 33 EFSA Journal 2016;14(3):4414 
 
References 
Bartlett JE, Kotrlik JW and Higgins CC, 2001. Organizational Research: Determining Appropriate 
Sample Size in Survey Research. Information Technology, Learning and Performance Journal, 19, 
43-50. 
CEFAS (Centre for Environment, Fisheries & Aquaculture Science), 2011. Investigation into the 
prevalence, distribution and levels of norovirus titre in oyster harvesting areas in the UK. Available 
online: http://www.food.gov.uk/sites/default/files/Norovirus%20surveillance%20report_0.pdf  
CEFAS (Centre for Environment, Fisheries & Aquaculture Science), 2014. Microbiological Monitoring 
of Bivalve Mollusc Harvesting Areas: Guide to Good Practice: Technical Application. Available 
online: www.cefas.defra.gov.uk   
Da Silva AK, Le Saux JC, Parnaudeau S, Pommepuy M, Elimelech M and Le Guyader FS, 2007. 
Evaluation of removal of noroviruses during wastewater treatment, using Real-Time Reverse 
Transcription-PCR: different behaviors of genogroups I and II. Applied and Environmental 
Microbiology, 73, 7891-7897. 
EC (European Commission), 2012. Community Guide to the Principles of Good Practice for the 
Microbiological Classification and Monitoring of Bivalve Mollusc Production and Relaying Areas 
with regard to Regulation 854/2004. 
EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2011. Scientific Opinion on An update on the 
present knowledge on the occurrence and control of foodborne viruses. EFSA Journal 
2011;9(7):2190, 96 pp. doi:10.2903/j.efsa.2011.2190 
EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2012. Norovirus (NoV) in oysters: methods, 
limits and control options. EFSA Journal 2012;10(1):2500, 39 pp. doi:10.2903/j.efsa.2012.2500 
EFSA (European Food Safety Authority), 2013a. Sample Size Considerations for Hierarchical 
Populations. EFSA Journal 2013;11(7):3292, 47 pp. doi:10.2903/j.efsa.2013.3292 
EFSA (European Food Safety Authority), 2013b. Standard Sample Description ver. 2.0. EFSA Journal 
2013;11(10):3424, 114 pp. doi:10.2903/j.efsa.2013.3424 
Ensoy C, Rakhmawati TW, Faes C and Aerts M, 2015. Separation Issues and Possible Solutions: Part 
II – Comparison of different methods for separation in logistic regression. EFSA supporting 
publication 2015:EN-869. 176 pp. 
Milanzi E, Njeru Njagi E, Bruckers L and Molenberghs G, 2015. Data Representativeness: Issues and 
Solutions. EFSA supporting publication 2015:EN-759, 159 pp. 
Hall AJ, Lopman BA, Payne DC, Patel MM, Gastañaduy PA, Vinjé J and Parashar UD, 2013. Norovirus 
Disease in the United States; Emerging Infectious Diseases, 19, 1198-1205. 
doi:10.3201/eid1908.130465 
Hoehne M and Schreier E, 2006. Detection of Norovirus genogroup I and II by multiplex real-time 
RT- PCR using a 3'-minor groove binder-DNA probe. BMC Infectious Diseases, 6, 69. 
Le Guyader FS, Parnaudeau S, Schaeffer J, Bosch A, Loisy F, Pommepuy M and Atmar RL, 2009. 
Detection and quantification of noroviruses in shellfish. Applied and Environmental Microbiology, 
75, 618-624. 
Loisy F, Atmar RL, Guillon P, Le Cann P, Pommepuy M and Le Guyader FS, 2005. Real-time RT-PCR 
for norovirus screening in shellfish. Journal of Virological Methods, 123, 1-7. 
Kageyama T, Kojima S, Shinohara M, Uchida K, Fukushi S, Hoshino FB, Takeda N and Katayama K, 
2003. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time 
quantitative reverse transcription-PCR. J Clin Microbiol. 41(4):1548-1557. 
Maguire AJ, Green J, Brown DWG, Desselberger U and Gray JJ, 1999. Molecular Epidemiology of 
Outbreaks of Gastroenteritis Associated with Small Round-Structured Viruses in East Anglia, 
United Kingdom, During the 1996–1997 Season. Journal of Clinical Microbiology, 37, 81-89. 
Pintó RM, Costafreda MI and Bosch A, 2009. Risk assessment in shellfish-borne outbreaks of hepatitis 
A. Applied and Environmental Microbiology, 75, 7350-7355. 
Survey of norovirus in oysters 
 
 
 
 
www.efsa.europa.eu/efsajournal 34 EFSA Journal 2016;14(3):4414 
 
Pommepuy M, Le Guyader FS, Le Saux J-C, Guilfoyle F, Dore B, Kershaw S, Lees D, Lowther JA, 
Morgan OC, Romalde  J, Furones D and Roque A, 2008. Reducing microbial rik associated with 
shellfish in European countries. In: Improving seafood products for the consumer. Ed T. 
Borrensen, Whoohead publishing, 212-246. 
Schaeffer J, Le Saux JC, Lora M, Atmar RL and Le Guyader FS, 2013. Norovirus contamination on 
French marketed oysters. International Journal of Food Microbiology, 166, 244-248. 
doi:10.1016/j.ijfoodmicro.2013.07.022.  
Svraka S, Duizer E, Vennema H, de Bruin E, van der Veer B, Dorresteijn B and Koopmans M, 2007. 
Etiological role of viruses in outbreaks of acute gastroenteritis in The Netherlands from 1994 
through 2005. Journal of Clinical Microbiology, 45, 1389-1394. 
Survey of norovirus in oysters 
 
 
 
 
www.efsa.europa.eu/efsajournal 35 EFSA Journal 2016;14(3):4414 
 
Abbreviations 
CA 
CEFAS 
DCF 
EURL 
LBM 
LOD 
Competent Authority 
Centre for Environment, Fisheries & Aquaculture Science 
data collection framework 
European Union Reference Laboratory 
Live Bivalve Molluscs 
limit of detection 
LOQ 
MS 
limit of quantification 
Member State/s 
NoV 
NRL 
PAFF 
PCR 
RT-PCR 
Norovirus 
National Reference Laboratory 
Standing Committee on Plants, Animals, Food and Feed 
polymerase chain reaction 
reverse transcription polymerase chain reaction 
SRS 
XML 
simple random sampling schemes 
Extensible mark-up language 
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Appendix A – Oyster production figures 
Table 7:  Proportional allocation of dispatch centres to be sampled (dispatch centres currently 
active handling C. gigas and/or O. edulis 
Country Average 
(2009–2013) 
tonnes  
C. gigas21) 
Average (2009–
2013) tonnes 
O. edulis 22) 
Proportion of EU 
production 
Total sales 
volume 1,000 
tonnes23 2012 
Croatia  40.7426 0.04%  
France 88,603 987.98 89.03% 
 
118.4 
Germany 82  0.08%  
Ireland 7,317.88 
 
310.94 
 
7.58% 
 
7.4 
Netherlands  140.14 0.14% 3.5 
Portugal    0.8 
Spain 648.811 760.1182 1.40%  
United Kingdom 1,635.72 97.97 
 
1.72% 
 
 
Grand Total 98,287 2,338 100.00%  
                                                          
21  FAO fishstat http://www.fao.org/fishery/statistics/en 
22  see footnote 21 
23  http://stecf.jrc.ec.europa.eu/documents/43805/839433/2014-11_STECF+14-18+-+EU+Aquaculture+sector_JRC93169.pdf 
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Table 8:  First sale/landings of oysters in 2014 (volume kg(a)) by month and country 
 Month 
Country Jan Feb Mar Apr May Jun Jul Aug Sep 10 11 12 Totals 
Denmark   9,671 24,360     30 8,570 24,712 15,996 83,339 
France 3,005 1,864 2,092 1,061 1,130 953 1,132 2,250 1,566 3,804 19,773 15,827 54,457 
Netherlands            11 11 
Portugal 3,646 3,957 3,956 8,293 7,676 8,565 7,475 7,524 6,751 5,334 652 2,221 66,050 
United Kingdom 878.5 931.5 100 1,597 1,801   764 382.4 187 26,165 921.7 33,728.1 
Totals 7,529.50 6,752.50 15,819 35,311 10,607 9,518 8,607 10,538 8,729.40 17,895 71,302 34,976.70 237,585 
 Appendix B –  Appendix C –  Appendix D –  Appendix E –  Appendix F –  Appendix G –  Appendix H –  Appendix I –  Appendix J –  Appendix K –  Appendix L –  Appendix M –  Appendix N –  Appendix O –  (a): http://www.eumofa.eu/adhoc/topics/market_mon 
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Appendix B – Method specification for laboratory analysis 
Quantitative detection of norovirus genogroup I and 
genogroup II in oysters 
Version 1 
Whereas every precaution has been taken in the preparation of this method specification, Cefas 
cannot be held responsible for the accuracy of any statement or representation made nor the 
consequences arising from the use of or alteration to any information contained within. All references 
to Cefas must be removed if any alterations are made to this method specification. 
 
European Union Reference laboratory for 
monitoring bacteriological and viral 
contamination of bivalve molluscs 
 
The Centre for Environment, Fisheries & 
Aquaculture Science, 
Weymouth Laboratory, 
Barrack Road, 
The Nothe, 
Weymouth,  
Dorset, DT4 8UB, UK 
Tel: +44 (0)1305 206600, Fax +44 (0)1305 206601  
Email: fsq@cefas.co.uk  http://www.crlcefas.org 
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1. Introduction 
Laboratories performing norovirus analysis for the European Food Safety Authority (EFSA) European 
Union (EU)-wide baseline survey in oysters are required to be designated by the Competent 
Authority (CA) of the Member State (MS). The analysis in each designated laboratory is required to 
be supervised by the National Reference Laboratory (NRL). This method specification has been 
compiled and agreed by the European Reference Laboratory (EURL)/EFSA technical working group 
comprised of representatives from the EURL and EFSA, and NRLs of France, Ireland, Germany, 
Denmark and Italy, and sets out the procedures that designated laboratories are required to follow in 
performing analysis of oysters submitted under this survey.  
This method specification is based on, and is compliant with, ISO/DIS 15216-1; Microbiology of the 
food chain -- Horizontal method for determination of hepatitis A virus and norovirus in food using 
real-time RT-PCR -- Part 1: Method for quantification (the initial draft revision to the ISO method 
including validation data). Accordingly, there are some differences to the current published technical 
specification ISO/TS 15216-1:2013. Furthermore, ISO/DIS 15216-1 has now passed the ISO Enquiry 
Stage and is due to be revised into a final draft (FDIS) in response to Technical comments received 
by the voting National Standards bodies. Following approval, the FDIS will be published as an 
International Standard (projected publication date last quarter of 2016). Further modifications to this 
method specification may therefore be necessary to harmonise fully with the agreed text of the FDIS 
(and by extension the forthcoming published ISO) prior to the start of the baseline survey. However, 
it is anticipated that any such changes will be comparatively minor and will not affect laboratories’ 
ability to undertake the analytical method. The EURL will circulate further information as it becomes 
available. 
In this method, specification flexibility in reagents and processes is allowed consistent with the text 
of ISO/DIS 15216-1; however, more detailed methods as recommended by the EURL are included as 
appendices for information. 
In addition to detailed methods in the appendices, the EURL will offer, on request, additional support 
to designated laboratories in the form of ready-to-use control materials (dsDNA and EC RNA for both 
norovirus genogroup I (GI) and genogroup II (GII), and mengo virus strain MC0 for use as process 
control), and a spreadsheet for calculation of results from the raw data (Cq values). Use of control 
materials and the quantification spreadsheet provided by the EURL is not mandatory. In all cases, 
designated laboratories, prior to initiation of analysis, must produce a detailed bench protocol for use 
in their laboratory for the duration of the baseline survey, which is consistent with the text of this 
method specification, and agreed with their NRL. This protocol must cover all stages of the process 
including generation of control materials. It is the responsibility of the NRL to ensure that all 
laboratory protocols proposed in their MS are compliant with this method specification and to 
maintain electronic copies of these documents for future review. 
3. Safety precautions 
Standard microbiology safety precautions should be applied throughout. Laboratories should perform 
a full risk assessment before performing this procedure.  
4. Equipment 
 micropipettes; 
 micropipette tips of a range of sizes, 1000 μl, 200 μl, 20 μl and 10 μl; 
 pipette filler; 
 pipettes of a range of sizes, 10 ml, 5 ml; 
 vortex mixer; 
 shaking incubator operating at 37C and 320 rpm or equivalent; 
 aspirator or equivalent apparatus for removing supernatant; 
 waterbath capable of operating at 60C or equivalent; 
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 bench centrifuge and rotor capable of running at 3,000 x g with capacity, for  15 or 50-ml 
tubes; 
 microcentrifuge; 
 balance; 
 centrifuge and microcentrifuge tubes/bottles of a range of sizes, 1.5 ml, 15 ml, 50 ml, etc.;  
 sterile shucking knife (for opening shellfish) or equivalent; 
 rubber block for shucking (opening) shellfish or equivalent; 
 scissors and forceps for dissecting shellfish or equivalent; 
 heavy duty safety glove; 
 sterile Petri dishes; 
 razor blades; 
 RNA extraction equipment suitable for extraction methods using silica and associated 
reagents. See Addendum 1 for illustrative details of RNA extraction apparatus as 
recommended by the EURL; 
 PCR machine with real-time capacity capable of supporting hydrolysis probe (TaqMan®) 
chemistry; 
 consumables for real-time PCR, e.g. optical plates and caps. 
5. Reagents  
5.1. Reagents used as purchased 
 molecular biology grade water; 
 tris base; 
 EDTA; 
 sodium chloride (NaCl); 
 potassium chloride (KCl); 
 disodium hydrogenphosphate (Na2HPO4); 
 potassium dihydrogenphosphate (KH2PO4); 
 proteinase K (30 U/mg); 
 silica, lysis, wash and elution buffers for extraction of viral RNA. Reagents shall enable 
processing of 500 μl of supernatant, using lysis with a chaotropic buffer containing guanidine 
thiocyanate and using silica as the RNA-binding matrix. Following treatment of silica-bound 
RNA with wash buffer(s) to remove impurities, RNA shall be eluted in 100 μl elution buffer; 
 the RNA preparation shall be of a quality and concentration suitable for the intended purpose. 
See Addendum 1 for illustrative details of RNA extraction reagents as recommended by the 
EURL; 
 reagents for one-step real-time RT-PCR using hydrolysis probes (Taqman®). Reagents shall 
allow processing of 5 μl RNA in 25 μl total volume. They shall be sufficiently sensitive for the 
detection of levels of virus RNA as typically found in virus-contaminated oysters. See 
Addendum 3 for illustrative details of one-step real-time RT-PCR reagents as recommended 
by the EURL; 
 primers and hydrolysis (Taqman®) probes for detection of norovirus GI and GII. Primer and 
probe sequences shall be published in a peer-reviewed journal and be verified for use 
against a broad range of strains of target virus. Primers shall target the ORF1/ORF2 junction 
of the genome. See Addendum 2 for illustrative details of primers and probes as 
recommended by the EURL; 
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 primers and hydrolysis (Taqman®) probes for detection of the process control virus. Primer 
and probe sequences shall be published in a peer-reviewed journal and be verified for use 
against the strain of process virus used. They shall demonstrate no cross-reactivity with 
norovirus genogroup I or genogroup II. See Addendum 2 for illustrative details of primers 
and probes as recommended by the EURL. 
5.2. Prepared solutions/buffers 
 Proteinase K solution 
Add 20 mg proteinase K (30 U/mg) to 200 ml water. Shake to dissolve then store in working 
aliquots at < -15ºC for a maximum of 6 months. Once defrosted store aliquots refrigerated 
and use within 1 week. 
 1 M Tris solution 
Add 121 g Tris base to 1,000 ml water. Shake to dissolve, then adjust pH to 8.0 ± 0.2. 
Sterilise by autoclaving. 
 0.5 M EDTA solution 
Add 186 g EDTA to 1,000 ml water. Shake to dissolve, then adjust pH to 8.0 ± 0.2. Sterilise 
by autoclaving. 
 TE buffer 
Mix together 1 ml 1 M Tris solution, 200 μl 0.5 M EDTA solution and 100 ml water. Shake to 
mix. Alternatively use a commercial TE buffer preparation. 
 PBS buffer 
Add 8 g sodium chloride, 0.2 g potassium chloride, 1.15 g disodium hydrogenphosphate and 
0.2 g potassium dihydrogenphosphate to 1,000 ml water. Shake to dissolve, then adjust pH 
to 7.3 ± 0.2. Sterilise by autoclaving. Alternatively use a commercial PBS buffer preparation. 
 Real-time RT-PCR mastermixes for norovirus and process control virus. 
Reagents shall be added in quantities as specified by the manufacturers to allow 20 μl 
mastermix per reaction in a 25 μl total volume. Optimal primer and probe concentrations 
shall be used after determination following the recommendations of the reagent 
manufacturers. See Addendum 3 for illustrative details of real-time RT-PCR mastermixes as 
recommended by the EURL. 
Note: Real-time RT-PCR mastermixes must be prepared no more than 24 h before 
use. Short-term storage (< 24 hours) at 2–6ºC is appropriate. Always prepare 
enough buffer for at least one reaction more than required (for larger 
preparations a greater number of excess reactions may be necessary).  
5.3. Control materials 
 Process control virus 
The virus selected for use as a process control shall be a culturable non-enveloped positive-
sense ssRNA virus of a similar size to norovirus to provide a good morphological and 
physicochemical model. The process control virus shall exhibit similar persistence in the 
environment to norovirus. The virus shall be sufficiently distinct genetically from norovirus 
that real-time RT-PCR assays for norovirus and the process control virus do not cross react, 
and the process control virus shall not normally be expected to occur naturally in oysters. 
Process control virus stock shall be diluted by a minimum factor of 10 in a suitable buffer, 
e.g. PBS. This dilution shall allow for inhibition-free detection of the process control virus 
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genome using real-time RT-PCR, but still be sufficiently concentrated to allow reproducible 
determination of the lowest dilution used for the process control virus RNA standard curve. 
Split the diluted process control virus material into single use aliquots and store at -15°C or 
below. See Addendum 4 for illustrative details of the preparation of process control virus as 
recommended by the EURL. 
 Double-stranded DNA (dsDNA) control material.  
Purified linear DNA molecules carrying the target sequence for each norovirus genogroup 
shall be used. The sequence of the DNA molecules shall be verified prior to use. The 
preparations shall not cause RT-PCR inhibition. The concentrations of each dsDNA stock in 
template copies per microlitre shall be determined using an appropriate method, e.g. 
spectrophotometry, fluorimetry or digital PCR, then the stock shall be diluted in a suitable 
buffer, e.g. TE buffer [NOTE: Do not use water], to a concentration of 1 × 104 to 1 × 105 
template copies/μl. Split the diluted dsDNA control material into single use aliquots and store 
frozen at −15°C or below. See Addendum 5 for illustrative details of the preparation of 
dsDNA as recommended by the EURL. 
 External control RNA (EC RNA) 
Purified ssRNA carrying the target sequence for each norovirus genogroup shall be used. 
They shall contain levels of contaminating target DNA no higher than 0.1% and shall not 
cause RT-PCR inhibition. The concentrations of each EC RNA stock in copies per microlitre 
shall be determined then the stock shall be diluted in a suitable buffer, e.g. TE buffer (NOTE: 
Do not use water), to a concentration of 1 × 104 to 1 × 105 template copies/μl. Split the 
diluted EC RNA preparation (EC RNA control material) into single use aliquots and store 
frozen at −15 °C or below. See Addendum 6 for illustrative details of the preparation of EC 
RNA as recommended by the EURL.  
6. Method 
Sample extraction and real-time RT-PCR shall be carried out in separate working areas or rooms. 
Particular care should be taken to ensure that positive control materials are not introduced into 
sample extraction areas. 
6.1. Sampling and sample transport 
Sampling and sample transport must be carried out in accordance with the requirements laid out in 
the EFSA Technical Specification for the Baseline Survey as set out elsewhere in this document. 
6.2. Sample acceptance criteria and initial preparation 
Sample processing must be initiated within 72 h of sample collection. If this is not possible due to, 
for example, delays during transportation, the sample should be regarded as unsatisfactory and 
analysis should not be carried out. Samples must be received in an intact food grade plastic bag and 
properly packed in a cool box with ice packs. Samples should be regarded as unsatisfactory and 
analysis should not be carried out if on receipt at the laboratory the sample is frozen, the container is 
leaking, the shellfish are covered in mud or immersed in water or mud/sand. Upon receipt in the 
laboratory, the internal air temperature of the transit container should be recorded. For samples 
where more than 4 h have elapsed between collection and receipt, the internal air temperature 
should be between 0 and 10°C. If the internal air temperature is greater than 10°C, the sample 
temperature should be measured; this should not exceed 10°C. For samples where less than 4 h 
have elapsed between collection and receipt, internal air temperature should be less than the 
temperature recorded at the time of sampling. Samples should be regarded as unsatisfactory and 
analysis should not be carried out if the temperature recorded does not meet the criteria specified. 
Choose oysters that are alive according to the following criteria: 
 if any exposed flesh reacts to touch using a sterile shucking knife; 
 if oysters open and close of their own accord; 
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 if a tap on the shell causes closing or movement; 
 tightly closed shellfish. 
Discard all dead shellfish and those with obvious signs of damage. Select a minimum of 10 animals. 
More than 10 shellfish can be used, if necessary, to produce the required quantity of digestive glands 
(> 2 g of digestive glands must be produced, and if possible > 4 g should be produced). If fewer 
than 10 live, undamaged animals are available, or if < 2 g digestive glands are produced, analysis 
should not be carried out. 
Small amounts of mud and sediment adhering to the shell should be removed prior to opening by 
rinsing/scrubbing under cold, running tap water of potable quality. Shellfish should not be 
reimmersed in water as this may cause them to open. Weigh the selected oysters to determine the 
average weight of an individual oyster with shell in grams. 
6.3. Dissection of digestive glands 
Place the oyster on a rubber block or equivalent. Open the shells with a clean knife or equivalent. 
Ensure the hand holding the oyster is adequately protected, e.g. with a heavy-duty safety glove.  
Dissect out the digestive glands using scissors and forceps (or equivalent tools). 
Transfer to a clean petri dish and chop finely with a razor blade (or equivalent). 
Transfer a 2 g portion of chopped glands into a centrifuge tube. Process immediately, store at 4°C 
for up to 24 h, at -15°C or below for up to 6 months, or at -70°C or below for longer periods. The 
remaining chopped glands can be stored in 2 g aliquots at -15°C or below for up to 6 months, or at -
70°C or below for longer periods.  
6.4. Virus extraction 
Immediately before any batch of samples is processed, pool together sufficient aliquots of process 
control virus material for use with all samples (allow 10 l per sample plus 25 l excess).  
Retain a 20 l subsample of pooled material for RNA extraction and preparation of the standard 
curve. Store at 4ºC for a maximum of 24 h or at -15ºC or below for longer periods. 
Add 10 μl of process control virus material to the 2 g portion of chopped glands produced in Section 
7.3. Immediately add 2 ml of proteinase K solution and mix well.  
Incubate at 37°C in a shaking incubator or equivalent at 320 rpm for 60 min. 
Carry out a secondary proteinase K incubation by placing the tube in a water bath or equivalent at 
60ºC for 15 min. 
Centrifuge at 3,000 x g for 5 min, decant the supernatant, measure and record the volume in 
millilitre and retain for downstream testing (RNA extraction). Process immediately, store at 4°C for 
up to 24 h, at -15°C or below for up to 6 months, or at -70°C or below for longer periods. 
6.5. RNA extraction 
Note: For every set of samples, a negative extraction control consisting of 500 μl water 
should be extracted in parallel. 
Extract RNA from 500 μl of supernatant (retained from Section 7.4) for each sample using an 
appropriate method including lysis with a chaotropic buffer containing guanidine thiocyanate and 
using silica as the RNA-binding matrix as described in Section 6.1. 
Elute purified RNA into 100 μl of elution buffer and retain for real-time RT-PCR analysis. Extracted 
RNA shall be processed immediately, stored at 4°C for up to 24 h, at -15°C or below for up to 6 
months, or at -70°C or below for longer periods. 
Note: Freeze-thaw cycles of stored RNA should be minimised. 
See Addendum 1 for illustrative details of an RNA extraction method as recommended by the EURL. 
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6.6. Real-time RT-PCR analysis – general requirements 
Real-time RT-PCR analysis for all targets need not be carried out on the same plate – however, the 
following restrictions must be observed; 
Full sets of norovirus GI or GII assay control reactions (dsDNA dilution series, EC RNA and water 
only) should be used for every plate where sample RNA is assayed for that genogroup.  
Full sets of process control virus assay control reactions (RNA dilution series from all relevant batches 
of process control virus material and water only) must be included on every plate where sample RNA 
is assayed for process control virus. 
As results generated using 10−1 sample, RNA are only used in the event that RT-PCR inhibition is 
unacceptable for undiluted sample RNA (Section 7.10), it is permitted for laboratories to omit 10−1 
sample RNA from the initial analysis of norovirus GI, norovirus GII and process control virus. In this 
case, where undiluted sample RNA provides an unacceptable RT-PCR inhibition, samples should 
subsequently be retested for any/all affected genogroups and process control virus using 10−1 
sample RNA. Undiluted sample RNA does not need to be retested at this stage. 
6.7. Real-time RT-PCR plate set-up – analysis of norovirus GI and/or 
GII 
Note: This section describes plate set-up for a single genogroup.  
Before starting 96-well real-time PCR plate preparation, prepare 10-1 dilutions of each sample RNA in 
water. (NOTE: If diluted RNA is not included in the initial analysis as described in Section 7.6, this 
step does not need to be carried out and wells using 10−1 sample RNA can be omitted). 
Prepare 10-1, 10-2, 10-3 and 10-4 dilutions of target dsDNA control material in a suitable buffer (e.g. TE 
buffer) (NOTE: Do not use water). 
For each sample, prepare: 
 two wells of an optical plate with 5 μl of undiluted sample RNA; 
 two wells with 5 μl of 10−1 sample RNA; 
 one well with 5 μl of undiluted sample RNA and 1 μl of undiluted EC RNA; 
 one well with 5 μl of 10−1 sample RNA and 1 μl of undiluted EC RNA. 
For the EC RNA control, prepare: 
 one well with 5 μl of water and 1 μl of undiluted EC RNA. 
For the dsDNA standard curve, prepare: 
 two wells with 5 μl of undiluted dsDNA; 
 two wells with 5 μl of 10−1 dsDNA; 
 two wells with 5 μl of 10−2 dsDNA; 
 two wells with 5 μl of 10−3 dsDNA; 
 two wells with 5 μl of 10−4 dsDNA. 
For negative controls, prepare: 
 two wells with 5 μl of water; 
 two wells with 5 μl of negative extraction control RNA. 
Add 20 μl of the relevant real-time RT-PCR mastermix to each well (mastermix may also be added to 
all relevant wells before addition of template material). 
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6.8. Real-time RT-PCR plate set-up – analysis of process control virus  
Before starting 96-well real-time PCR plate preparation, prepare 10-1 dilutions of each sample RNA in 
water. (NOTE: If diluted RNA is not included in the initial analysis as described in Section 7.6, this 
step does not need to be carried out and wells using 10−1 sample RNA can be omitted). 
For each batch used with the samples under test, add 10 μl of process control virus material to a 
separate 500 μl portion of water. Extract and store RNA for each batch using the same method and 
conditions applied to the test samples. 
For each batch of process control virus material extracted, prepare 10-1, 10-2 and 10-3 dilutions of 
process control virus RNA in a suitable buffer (e.g. TE buffer) (NOTE: Do not use water). 
For each sample, prepare: 
 one well with 5 μl of undiluted sample RNA; 
 one well with 5 μl of 10−1 sample RNA. 
For the process control virus RNA standard curve, prepare: 
 one well with 5 μl of undiluted process control virus RNA; 
 one well with 5 μl of 10−1 process control virus RNA; 
 one well with 5 μl of 10−2 process control virus RNA; 
 one well with 5 μl of 10−3 process control virus RNA. 
For negative controls, prepare: 
 one well with 5 μl of water; 
 one well with 5 μl of negative extraction control RNA. 
Add 20 μl of process control virus real-time RT-PCR mastermix to each well (mastermix may also be 
added to all relevant wells before addition of template material). 
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Figure 6:  Example plate layout (single sample – all assays on one plate) including wells with 10−1 sample RNA 
NOTE: This layout includes wells with 10−1 sample RNA, however, these can be omitted from the initial analysis as described in Section 7.6
 
5 μl RNA (+/- 1 μl EC RNA) and 20 μl mastermix per well 
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Figure 7: Example plate layout (single sample – all assays on one plate) omitting wells with 10−1 sample RNA 
NOTE: This layout omits wells with 10−1 sample RNA as described in Section 7.6 
 
5 μl RNA (+/- 1 μl EC RNA) and 20 μl mastermix per well
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6.9. Real-time RT-PCR assay run parameters 
Subject the plate to a reaction cycle including an initial stage for reverse transcription and at least 45 
cycles of PCR using a real-time RT-PCR machine. The duration and temperatures of each stage 
(reverse transcription, RT deactivation, denaturation, annealing and extension) depends on the 
reagents used; they shall be based on the manufacturer’s recommendations, but can be further 
optimised. 
For real-time RT-PCR machines where the user can set the point of fluorescence data collection, this 
shall be set at the end of the extension stage. 
See Addendum 3 for illustrative details of an amplification method as recommended by the EURL. 
6.10. Analysis of results 
Note: The EURL will provide a calculation spreadsheet for this method on its website to 
support laboratories carrying out the analysis of results; this will make all necessary 
calculations based on the input Cq values. Its use is not mandatory however. 
Analyse the amplification plots using the approach recommended by the manufacturer of the real-time 
PCR machine. The threshold should be set so that it crosses the area where the amplification plots 
(logarithmic view) are parallel (the exponential phase). 
Check all amplification plots to identify false positive results (reactions with Cq values not associated 
with exponential amplification) caused by high or uneven background signal. Results for any wells 
affected in this way should be regarded as negative. An example is provided in the image below. 
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Check all amplification plots to identify true positive plots where the recorded Cq value is significantly 
distorted by high or uneven background signal. Approximate correct Cq values should be noted (in 
addition to the recorded value) for any wells affected in this way. Corrected Cq values should be used 
for all quantity calculations. 
 
For example, in this case the recorded Cq value was 34.92, however, it should be noted by the 
laboratory that the correct figure should be, for example, 38.  
Each control (dsDNA, EC RNA, process control virus RNA) has an expected valid value or range of 
values. If the observed result for any control is different from the expected value, samples may 
require retesting. 
Negative controls (water and negative extraction control) shall always be negative; if positive results 
occur in these controls, then any samples giving positive results shall be retested. 
Check Cq values of all standard curves for any points that do not fall close to the line of best fit. These 
Cq values should not be incorporated into standard curve calculations. No more than two such 
outlying Cq values shall be removed per series and values from a minimum of three (process control 
virus RNA) or four dilutions (dsDNA) must be included.  
Use the remaining Cq values of each dilution series to create standard curves for each control by 
plotting the Cq values obtained against log10 concentration (e.g. log10 copies per microlitre target 
dsDNA) to determine r2, slope and intercept parameters. Do not average Cq values from duplicate 
reactions prior to plotting.  
Curves with r2 values of < 0.980, or where the slope is not between -3.10 and -3.60 (corresponding 
to amplification efficiencies of ~90–110%), should not be used for calculations. 
Use the Cq value for the undiluted sample RNA + EC RNA well to determine the RT-PCR inhibition 
levels for each sample and each norovirus genogroup by reference to the Cq value of the water + EC 
RNA well and the slope of the dsDNA standard curve as follows:- 
RT-PCR inhibition = (1-10(ΔCq/slope)) x 100% 
where ΔCq = Cq value [sample RNA + EC RNA] - Cq value [water + EC RNA] 
A sample (+ EC RNA) producing the same Cq values as undiluted EC RNA will have an RT-PCR 
inhibition level of 0%. 
If the RT-PCR inhibition level is < 75% results for the undiluted RNA should be used for that sample 
and target. If the RT-PCR inhibition level is > 75%, repeat calculation with the 10-1 sample RNA + EC 
RNA wells for the same target (or repeat PCR using 10-1 sample RNA if this is not included in the initial 
analysis as described in Section 7.6). If the RT-PCR inhibition level using the 10-1 RNA is < 75%, 
results for the 10-1 RNA should be used for that sample and target. If RT-PCR inhibition levels for both 
undiluted and 10-1 sample, RNA are > 75% results are not valid and the sample should be retested.  
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Use the Cq value for the process control virus assay from the test sample RNA well (undiluted or 10-1 
dependent on the RT-PCR inhibition results; see above) to estimate process control virus recovery by 
reference to the process control virus RNA standard curve as follows (if 10-1 sample RNA results are 
used multiply by 10 to correct for the dilution factor): 
Process control virus recovery = 10(ΔCq/slope) x 100% 
 where ΔCq = Cq value [sample RNA] – Cq value [undiluted process control 
virus RNA] 
To determine the extraction efficiency, divide the process control virus recovery by 0.5 and multiply by 
the total measured volume of supernatant in millilitre (as determined in Section 7.4). Where the 
extraction efficiency is < 1% sample, results are not valid and the sample should be retested. 
For a sample with acceptable RT-PCR inhibition and extraction efficiency results, if one or more 
replicate results from the sample RNA only wells (undiluted or 10-1 dependent on the RT-PCR 
inhibition results; see above) for a given norovirus genogroup are positive, the overall result for that 
sample will be regarded as positive. If both replicate results are negative, then the overall result for 
that sample will be regarded as not detected. 
For each positive sample and norovirus genogroup, take the Cq values for the sample RNA only wells 
(undiluted or 10-1 dependent on the RT-PCR inhibition results; see above) and use these to calculate 
concentrations (in detectable virus genome copies/μl RNA) for each replicate by reference to the 
relevant dsDNA standard curve as follows:- 
concentration = 10(ΔCq/slope) 
where ΔCq = Cq value [sample RNA] – standard curve intercept 
Negative replicates should be given a concentration of zero copies/μl RNA. For each sample, calculate 
the average of the concentrations for both replicates. 
Multiply this value by 200 (undiluted RNA) or 2,000 (10−1 RNA) then multiply by the total volume of 
supernatant in millilitre (as determined in Section 7.4) to calculate the number of detectable virus 
genome copies in the entire sample. 
To obtain the concentration of the relevant norovirus genogroups in detectable virus genome copies 
per gram, divide the number of genome copies in the entire sample by the starting weight (2 g) of the 
sample. 
7. Retesting 
Where a sample provides an unacceptable RT-PCR inhibition level or extraction efficiency, or where 
control results indicate other problems with analysis, the samples should be retested according to the 
criteria outlined below.  
A sample that fails to provide an acceptable RT-PCR inhibition level or extraction efficiency on two 
occasions does not need to be subjected to further retesting. In this case, results for the affected 
sample and genogroup shall be reported as no result, unless an otherwise valid positive result is 
obtained on at least one of the two testing occasions, in which case the result shall be regarded as 
positive, not quantifiable. 
In all cases, test sample materials used for the retest must have been stored according to the relevant 
part of this protocol. 
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The following provides a list of situations where retesting may be required and 
recommendations for the appropriate procedure to undertake on retesting: 
For samples where results are affected by problems with RT- PCR, e.g.:  
 positive results in water only wells;  
 negative or unexpected results with dsDNA or EC RNA controls; 
 high background/low signal in general. 
Retest using stored RNA (Section 7.5). Test only those assays where results have been affected. 
Where samples are retested for process control virus, the appropriate batch of process control virus 
RNA must also be tested.  
For samples where negative extraction controls are contaminated (and negative RT-PCR 
controls – water only – are not contaminated): 
Retest using stored digestive glands (Section 7.3) provided that 2 g stored glands are available, 
otherwise retest using stored supernatant (Section 7.4). Only affected genogroups need to be tested, 
however, full process control virus controls to enable assessment of extraction efficiency specifically 
for the retest must be used. 
For samples where extraction efficiency is below the acceptable threshold: 
Retest using stored digestive glands (Section 7.3) provided that 2g stored glands are available; 
otherwise retest using stored supernatant (Section 7.4).   
For samples where RT-PCR inhibition level is above the acceptable threshold (after 
testing undiluted sample RNA, in the case that 10-1 sample RNA has not been included in 
the initial analysis as described in Section 7.6): 
Retest using stored RNA (Section 7.5). Prepare a 10-1 dilution prior to analysis, and do not repeat 
analysis using undiluted RNA.  Test only those assays where results have been affected. 
For samples where RT-PCR inhibition level is above the acceptable threshold (after 
testing 10-1 sample RNA): 
Retest using stored digestive glands (Section 7.3) provided that 2 g stored glands are available, 
otherwise retest using stored supernatant (Section 7.4). Only affected genogroups need to be tested, 
however, full process control virus controls to enable assessment of extraction efficiency specifically 
for the retest must be used. 
8. Sharing of analysis between multiple laboratories 
For practical purposes in some MSs, it may be helpful if different stages of the analysis of samples can 
be carried out in different laboratories. This is permitted with the approval of the NRL, provided that: 
 the overall protocol is consistent with this method specification; 
 transportation arrangements must ensure that during transfer between laboratories 
intermediate test sample materials (e.g. digestive glands, supernatant or RNA) do not exceed 
either the time or temperature limits detailed within this method specification. 
9. Two-stage PCR analysis 
For practical purposes in some MSs, it may be helpful if real-time RT-PCR analysis can be carried out 
in two stages, including an initial presence/absence screen, followed by quantification of positive 
samples. This is permitted with the approval of the NRL. In this case, analysis at each stage should be 
carried out according to Sections from 7.6 to 7.10 and 8.0 with the following exceptions: 
 a dsDNA standard curve shall not be used during the presence/absence screen, however, all 
other sample and control reactions as detailed in Sections 7.7 and 7.8 must be included; 
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 determination of RT-PCR inhibition and extraction efficiency for each sample and assessment 
of whether retesting is necessary shall be carried out as part of the presence/absence screen 
and shall not be repeated during the quantification stage; 
 to control for RT-PCR inhibition at the presence/absence screen stage, the method from 
ISO/TS 15216-2 shall be used;  if the Cq value of the undiluted sample RNA + EC RNA well is 
< 2.00 greater than the Cq value of the water + EC RNA well, results for the undiluted RNA 
shall be used for that sample. If the Cq value of the undiluted sample RNA + EC RNA well is 
≥2.00 greater than the Cq value of the water + EC RNA well, repeat the comparison with the 
10−1 sample RNA + EC RNA well; 
 if the Cq value of the 10−1 sample RNA + EC RNA well is < 2.00 greater than the Cq value of 
the water + EC RNA well, results for the 10−1 RNA shall be used for that sample. If the Cq 
value of the 10−1 sample RNA + EC RNA well is ≥2.00 greater than the Cq value of the water 
+ EC RNA well, the results are not valid and the sample requires retesting; 
 at the quantification stage, in addition to the dsDNA standard curve, two wells with 5 μl of 
water shall be used as the negative control, and one well with 5 μl of water and 1 μl of 
undiluted EC RNA shall be used as a generalised positive control for RT-PCR.  Other controls 
shall be omitted; 
 a sample that provides a positive result at the presence/absence screen stage, but does not 
provide a positive result at the quantification stage shall be regarded as positive; not 
quantifiable; 
 where the two stages of the PCR analysis are carried out at different laboratories 
transportation arrangements must ensure that during transfer between laboratories the RNA 
does not exceed either the time or the temperature limits detailed within this method 
specification; 
10. Reporting of results 
For each sample and each genogroup, the following information will be collected, using a common 
result reporting system, which will be maintained by EFSA: 
 average weight per oyster (with shells); 
 date of completion of analysis; 
 result (positive/ not detected/ no result); 
 for positive results, whether the sample was quantifiable or not quantifiable (as described in 
Sections 8 and 10); 
 for quantifiable positive results, the quantity determined in copies/g; this figure should not be 
censored according to any limit of quantification; 
 for positive not quantifiable results, whether this was due to failure to provide an acceptable 
RT-PCR inhibition level or extraction efficiency on two occasions or failure to detect the target 
during the quantification stage in a sample that was positive during the presence/absence 
screen stage where two-stage PCR as described in Section 10 is used; 
 the limit of quantification (LOQ) that applies to the result; 
 the limit of detection (LOD) that applies to the result where this is available. 
11. Sample archiving 
An archive of residual digestive glands, supernatant and RNA for all samples must be retained for 
each MS by the NRL or a single laboratory designated by the NRL for at least 2 years following the 
completion of the survey. Materials must be retained within the temperature limits described 
elsewhere in this method specification. Use of archived materials for alternative purposes is only 
allowed with the agreement of the relevant NRL and CA. 
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Addendum 1: RNA extraction using the Biomerieux NucliSens® System 
(informative) 
Equipment 
 NucliSens miniMAG magnetic rack. BioMerieux24, cat number; 200299. 
 NucliSens miniMAG instrument. BioMerieux25, cat number; 200305. 
 1.5 ml tubes with screw caps suitable for use with the miniMAG/easyMAG extraction systems. 
 Thermoshaker operating at 60ºC and 1400 rpm or equivalent.  
Reagents 
 NucliSens magnetic extraction reagents. BioMerieux26, cat numbers; 200293, etc.  
 NucliSens lysis buffer. BioMerieux27, cat numbers; 284135, 280134, etc.  
Method 
For each test sample, add 2 ml of NucliSens lysis buffer to a tube. Add 500 μl of supernatant 
produced in Section 7.4 and mix by vortexing briefly. 
Incubate for 10 min at room temperature. 
Add 50 μl of well-mixed magnetic silica solution to the tube and mix by vortexing briefly. 
Incubate for 10 min at room temperature. 
Centrifuge for 2 min at 1,500 x g then carefully discard supernatant by, for example, aspiration. 
Add 400 μl wash buffer 1 and resuspend the pellet by pipetting/vortexing. 
Transfer suspension to a 1.5 ml screw-cap tube. Wash for 30 s using the automated wash steps of the 
miniMAG/easyMAG extraction systems or by vortexing. After washing, allow silica to settle using 
magnet of the miniMAG/easyMAG extraction system. Discard supernatant by, for example, aspiration. 
Separate tubes from magnet, then add 400 μl wash buffer 1. Resuspend pellet, wash for 30 s, allow 
silica to settle using magnet then discard supernatant. 
Separate tubes from magnet, then add 500 μl wash buffer 2. Resuspend pellet, wash for 30 s, allow 
silica to settle using magnet then discard supernatant. Repeat. 
Separate tubes from magnet, then add 500 μl wash buffer 3. Wash for 15 s, allow silica to settle using 
magnet then discard supernatant. 
Note: Samples should not be left in wash buffer 3 for longer than strictly necessary. 
Add 100 μl elution buffer, cap tubes and transfer to thermoshaker or equivalent. 
Incubate for 5 min at 60ºC with shaking at 1,400 rpm. 
Place tubes in magnetic rack and allow silica to settle, then transfer eluate to a clean tube. Process 
immediately, store at 4°C for up to 24 h, at -15°C or below for up to 6 months, or at -70°C or below 
for longer periods. 
                                                          
24 http://www.biomerieux.com/ 
25 see footnote 24 
26 see footnote 24 
27 see footnote 24 
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Addendum 2: Primer and probe sequences (informative) 
Norovirus GI 
QNIF4 (FW): CGC TGG ATG CGN TTC CAT [da Silva et al., 2007] 
NV1LCR (REV): CCT TAG ACG CCA TCA TCA TTT AC  [Svraka et al., 2007] 
TM9 (PROBE): TGG ACA GGA GAT CGC [Hoehne & Schreier, 2006] 
Probe labelled 5’ FAM, 3’ MGBNFQ 
Norovirus GII 
QNIF2 (FW): ATG TTC AGR TGG ATG AGR TTC TCW GA [Loisy et al., 2005] 
COG2R (REV): TCG ACG CCA TCT TCA TTC ACA [Kageyama et al., 2003] 
QNIFS (PROBE): AGC ACG TGG GAG GGC GAT CG [Loisy et al., 2005] 
Probe labelled 5’ FAM, 3’ 6-carboxy-tetramethylrhodamine (TAMRA) 
Mengo virus 
Mengo 110 (FW): GCG GGT CCT GCC GAA AGT [Pintó et al., 2009] 
Mengo 209 (REV): GAA GTA ACA TAT AGA CAG ACG CAC AC [Pintó et al., 2009] 
Mengo 147 (PROBE): ATC ACA TTA CTG GCC GAA GC [Pintó et al., 2009] 
Probe labelled 5’ FAM, 3’ MGBNFQ 
pTAG (for pGEM series plasmids) 
pTAG 5:  GCT ATG ACC ATG ATT ACG CCA A  [Maguire et al., 1999] 
pTAG 3: TGT AAA ACG ACG GCC AGT GAA [Maguire et al., 1999] 
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Addendum 3: Real-time RT-PCR mastermixes and cycling parameters 
(informative) 
Real-time (Taqman®) RT-PCR mastermixes are prepared using the RNA Ultrasense One-step qRT-PCR 
system. Thermo Scientific catalogue number; 11732927.
28
  
Reagent 
Final concentration 
(in 25 μl) 
Volume per reaction 
(μl) 
5× Ultrasense reaction mix 1× 5 
FW Primer 0.5 pmol/µl As required 
REV Primer 0.9 pmol/µl As required 
Probe 0.25 pmol/µl As required 
ROX reference dye (50×) As require(a) As required 
RNA Ultrasense enzyme mix — 1.25 
Water — As required 
Total volume — 20 
(a)  With Applied Biosystems real-time RT-PCR machines, ROX shall be used at 1× concentration; for the Stratagene MX3000, 
ROX can be either used at 0,1× concentration, or omitted from the mastermix. For other machines, consult the 
manufacturer's instructions. 
 
Cycling parameters 
Step description  Temperature and time Number of cycles 
RT  55°C for 1 h 1 
Preheating  95°C for 5 min 1 
Amplification 
 
Denaturation 95°C for 15 s 
45 
 
Annealing-
extension 
60°C for 1 min 
65°C for 1 min 
Addendum 4: Growth of mengo virus strain MC0 for use as a process 
control (informative) 
Note: For preparation of this, control material laboratories will require cell culture 
facilities including incubator(s), preferably with controllable CO2 levels, cell culture 
consumables (flasks, etc.) and media.  
The EURL will, on request, provide ready-to-use mengo virus process control material 
(prepared as detailed below) to designated laboratories to cover the analysis of samples 
during the EFSA baseline survey. 
Mengo virus strain MC0 (ATCC VR-1597) should be used unless proscribed by e.g. GMO regulations. In 
this case, wild-type mengo virus (ATCC VR-1598) can be used. Mengo virus should best be grown in a 
5% CO2 atmosphere (with open vessels) or an uncontrolled atmosphere (closed vessels) on 80–90% 
confluent monolayers of HeLa cells (ATCC CCL-2). Recommended cell culture medium for this cell line 
is: 
Eagle’s minimum essential medium with 
2mM L-glutamine 
Earle’s BSS, adjusted to 
1.5 g/l sodium bicarbonate 
                                                          
28 http://www.thermoscientific.com/content/dam/tfs/SDG/MBD/MBD%20Marketing%20Material/Food/LifeTech-Micro-Product%
20List-EN.pdf 
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0.1 mM non-essential amino acids 
1.0 mM sodium pyruvate 
1% streptomycin/penicillin 
10% (growth) or 2% (maintenance) foetal bovine serum 
Alternatively, virus can be grown on FRhK-4 cells (ATCC CRL-1688). Recommended cell culture 
medium for this cell line is:  
Dulbecco’s modified Eagle’s medium with 
4mM L-glutamine, adjusted to 
1.5 g/l sodium bicarbonate 
4.5 g/l glucose 
1% streptomycin/penicillin 
10% (growth) or 2% (maintenance) fetal bovine serum 
To prepare mengo virus for process control, freeze and thaw a culture flask in which at least 75% 
cytopathic effect (CPE) has been reached, centrifuge flask contents at 3,000 x g for 10 min to clarify 
and retain supernatant. Dilute by a minimum factor of 10x in sample buffer, e.g. PBS, split into single 
use aliquots and store frozen at -80C. This dilution must allow for inhibition-free detection of the 
process control virus genome using real-time RT-PCR but still be sufficiently concentrated to allow 
reproducible determination of the lowest dilution used for the process control virus RNA standard 
curve. 
Addendum 5: Generation of double-stranded DNA (dsDNA) control stocks 
(informative) 
Note: For preparation of these control materials, laboratories will require capabilities for 
transformation and growth in solid and liquid media of E.coli, capabilities or kits for 
plasmid preparation, conventional PCR and purification of DNA from reaction mixes (in 
addition to the listed products) and a spectrophotometer capable of measuring at 260 and 
280 nm. Special care shall be taken to separate work areas used for generation of dsDNA 
control stocks from those used for sample extraction.  
The EURL will, on request, provide ready-to-use dsDNA control material (prepared as 
detailed below) to designated laboratories to cover the analysis of samples during the 
EFSA baseline survey. However, please note that control material supplied by the EURL or 
generated using the method below will not work with all permissible primer/probe sets. 
If primer and probe sets different to those illustrated in Addendum 2 are used, it is the 
responsibility of the designated laboratory and the relevant NRL to ensure that dsDNA 
control material suitable for the primer/probe set selected is used. 
Norovirus control plasmids used by the EURL were developed by Dr Françoise S. Le Guyader (Le 
Guyader et al., 2009). For norovirus, GI and GII control plasmids were separately constructed by 
ligating the target DNA sequence into the pGEM-3Zf(+) vector at a SmaI restriction site such that in 
each case the target sequence was downstream of a promoter sequence for the T7 RNA polymerase. 
The EURL can supply starter aliquots of these plasmids to laboratories upon request. 
The plasmid should be transformed and maintained in, and purified from, E. coli cells using standard 
molecular and microbiology techniques. Following purification of plasmid by e.g. commercial miniprep, 
linear DNA molecules suitable for use as quantification controls can be generated by PCR 
amplification of an amplicon spanning the target region using a dilute solution of the plasmid as 
template and the pTAG 5 and pTAG 3 primer set (see Addendum 2 for primer sequences). 
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The linear dsDNA control should be verified by sequencing. Expected sequences (virus-derived 
sequences in bold) are: 
Norovirus GI  
TGTAAAACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGAATTCGAGCTCGGTACCCCGCTGGAT
GCGCTTCCATGACCTCGGATTGTGGACAGGAGATCGCGATCTTCTGCGGATCCGAATTCGTAAATG
ATGATGGCGTCTAAGGGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGAGTATTCTATAGTGTC
ACCTAAATAGCTTGGCGTAATCATGGTCATAGC 
Norovirus GII 
TGTAAAACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGAATTCGAGCTCGGTACCCATGTTCAGA
TGGATGAGATTCTCAGATCTGAGCACGTGGGAGGGCGATCGCAATCTGGCTCGGATCCCCAGCTTT
GTGAATGAAGATGGCGTCGAGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGAGTATTCTATAG
TGTCACCTAAATAGCTTGGCGTAATCATGGTCATAGC 
Following generation of linear control DNA, a small amount should be cleaned up using, for example, 
a commercial PCR purification kit. The concentration of DNA can then be calculated using spectral 
absorption at 260 nm (spectral absorption at 280 nm should also be carried out to monitor the purity 
of the DNA preparation, highly pure DNA should have an A260/280 ratio of around 1.8).  
Multiplication of the A260 value by 5 x 10-8 (and by any dilution factor involved) will give the 
concentration of DNA in g/μl. 
Divide this number by the mass in grams of a single dsDNA molecule to calculate the concentration of 
DNA in copies/μl (the mass of an individual dsDNA molecule is calculated by multiplying the length in 
bp by 607.4 (the molecular weight of an average bp) and dividing by the Avogadro constant (6.02  
1023). 
For the pTAG, PCR products amplified from the plasmids used by the EURL the masses are as follows: 
 Norovirus GI 2.45x10-19g  (242 bp) 
 Norovirus GII 2.50x10-19g  (247 bp) 
The preparation of linear dsDNA should then be diluted with a suitable buffer (e.g. TE buffer) (NOTE: 
do not use water) to a concentration of approximately 1x104–1x105 copies/μl, and frozen in single use 
aliquots. 
Addendum 6: Generation of external control RNA (EC RNA) control stocks 
(informative) 
Note: For preparation of these control materials, laboratories will require capabilities for 
transformation and growth in solid and liquid media of E. coli, capabilities or kits for 
plasmid preparation, purification of DNA from reaction mixes (in addition to the listed 
products) and a spectrophotometer capable of measuring at 260 nm. Special care shall be 
taken to separate work areas used for generation of dsDNA control stocks from those 
used for sample extraction.  
The EURL will, on request, provide ready-to-use EC RNA control material (prepared as 
detailed below) to designated laboratories to cover the analysis of samples during the 
EFSA baseline survey. However, please note that control material supplied by the EURL or 
generated using the method below will not work with all permissible primer/probe sets. 
If primer and probe sets different to those illustrated in Addendum 2 are used, it is the 
responsibility of the designated laboratory and the relevant NRL to ensure that EC RNA 
control material suitable for the primer/probe set selected is used. 
Control plasmids as described in Addendum 5 are used for the production of EC RNA. These plasmids 
should be transformed and maintained in, and purified from, E. coli cells using standard molecular and 
microbiology techniques. Following purification of plasmid by e.g. commercial miniprep, a small 
amount should be linearised using a suitable restriction enzyme (to enable linearisation of the plasmid 
at a point shortly downstream of the target sequence) and buffers as recommended by the 
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manufacturer of the enzyme. For the plasmids used by the EURL, linearise using XbaI enzyme. The 
reaction should then be cleaned up using e.g. a commercial PCR purification kit. 
For the plasmids used by the EURL, EC RNA can be in vitro transcribed using the SP6/T7 Riboprobe 
combination system (Promega, cat no. P1460
29
) as follows: 
Add the following components at room temperature in the order listed: 
5X transcription buffer    20 μl 
100 mM DTT     10 μl 
RNasin      2.5 μl 
rATP, rGTP, rCTP, rUTP mix (2.5 mM each) 20 μl 
linearised template DNA (max 1 μg/μl)  5 μl 
T7 polymerase (for norovirus GI/GII EC RNA) 3 μl 
water      39.5 μl 
Mix by pipetting 
Incubate for 2 h at 37ºC. 
Add 5 μl RQ1 RNase-free DNase to the reaction. 
Incubate for 15 mins at 37ºC. 
The RNA should then be purified using RNA purification reagents (e.g. QIAGEN RNeasy Mini Kit [cat 
nos. 74103, 74104, 74106
30] using the manufacturer’s RNA cleanup protocol) and eluting in 100l 
water. 
The RNA preparation should be checked for freedom from significant contamination with DNA by 
assaying for target both with and without RT activity, for example, by assaying with both real-time 
RT-PCR mastermix where RT has been deactivated by heating at 95ºC, and untreated mastermix. If 
levels of DNA contamination higher than 0.1% are found, the preparation should be subjected to 
further treatment(s) with DNase. 
The concentration of RNA can then be calculated using spectral absorption at 260 nm.  
Multiplication of the A260 value by 4 x 10-8 (and by any dilution factor involved) will give the 
concentration of RNA in g/μl. 
Divide this number by the mass in grams of a single EC RNA molecule to calculate the concentration 
of DNA in copies/μl (the mass of an individual RNA molecule is calculated by multiplying the RNA 
length in ribonucleotides by 320.5 (the molecular weight of an average ribonucleotide) and dividing by 
the Avogadro constant (6.02  1023). 
For the EC RNAs used by the EU-RL, the masses are as follows: 
 Norovirus GI 6.73 x 10-20 g  (126 b) 
 Norovirus GII 7.00 x 10-20 g  (131 b) 
The preparation of RNA transcripts should then be diluted with a suitable buffer (e.g. TE buffer) 
(NOTE: Do not use water) to a concentration of approximately 1x104–1x105 transcripts/μl, and frozen 
in single use aliquots.  
 
 
  
                                                          
29   http://www.promega.com/catalog/country_select.asp?/default.asp&ckt=2 
30   http://www1.qiagen.com/SelectCountry.aspx 
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Appendix C – Examples of sample forms 
 
Sample Form: Production Area  
 
Please check relevant grey shaded boxes and complete the green shaded boxes  
Sample reference number 
 
 
Country 
 
 
Production area code 
 
 
Production area name 
 
 
Classification at time of sampling 
 
A  
B  
C  
Fully classified  
Seasonal  
Preliminary  
Sampling Date and Time  
 
 
 
Day XX/ Month XX/ Year XXXX  - Hour XX 
Oyster Species O. edulis  
C. gigas  
C. angulata  
Location of representative sampling point 
(WGS84 format) 
Latitude Longitude 
 
 
 
Intertidal Inshore  Offshore 
   
Production system 
 
Farmed Wild 
  
Raised Trestle   
Suspended from sea-surface  
Bottom-grown  
Remarks, any unusual conditions at time 
of sampling or deviations from sampling 
plan 
 
 
 Sampler name 
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Sample Form: Dispatch Centre  
 
Please check relevant grey shaded boxes and complete the green shaded boxes 
Sample reference number 
 
 
Country 
 
 
Dispatch Centre Approval Number 
 
 
Sampling Date and Time  
 
 
 
Day XX/ Month XX/ Year XXXX  - Hour XX 
Oyster Species O. edulis  
C. gigas  
C. angulata  
Overall Batch Weight (Kgs) 
 
 
Production area 1: 
Production area code 
 
 
Production area name 
 
 
Classification at time of sampling 
 
A  
B  
C  
Date of harvesting 
 
 
 
Day XX/ Month XX/ Year XXXX  
Conditioning – duration in hours   
Relaying – duration in days   
Purification – duration in hours 
Indicate thermal status 
 
 
 
  
Ambient  
Actively heated  
Actively cooled  
Temperature  °C  
Oysters Origin 
 
 
Indicate country  
 
 
 
Indicate fishing area code or name 
Wild  
 
 
 
Farmed  
 
 
 
Production area 2 
Production area code 
 
 
Production area name 
 
 
Classification at time of sampling 
 
A  
B  
C  
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Date of harvesting 
 
 
 
Day XX/ Month XX/ Year XXXX  
Conditioning – duration in hours   
Relaying – duration in days   
Purification – duration in hours 
Indicate thermal status 
 
 
 
  
Ambient  
Actively heated  
Actively cooled  
Temperature  °C  
Oysters Origin 
 
 
Indicate country  
 
 
 
Indicate fishing area code or name 
Wild  
 
 
 
Farmed  
 
 
 
Remarks, any unusual conditions at time 
of sampling or deviations from sampling 
plan 
 
 
Sampler name  
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Appendix D – Supporting information 
 
Appendix D can be found in the online version of this output. 
